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ABSTRACT
Epidemiological evidence suggests that exposure to the metalloid arsenic constitutes a 
risk factor for cardiovascular disease. Some of the cardiovascular effects attributed to 
arsenic are decreased cardiac function, peripheral vascular diseases and atherosclerosis. 
While the epidemiological evidence linking arsenic to cardiovascular (CVD) is abundant, 
the mechanisms of action are primarily unknown. The purpose of this study is to begin 
elucidating those mechanisms by (1) defining the changes in key atherogenic regulatory 
molecules upon exposure to arsenic in bovine aortic endothelial cells (BAE) (2) 
investigating the effects of arsenite on the formation of reactive oxygen (ROS) and 
reactive nitrogen species (RNS) in endothelial cells and (3) determining the effects of 
arsenite on atherogenesis and expression of key CVD regulatory molecules in the ApoE'/* 
/LDLr7" atherosclerotic mouse model. This model develops severe atherosclerotic 
plaques early in life. We were able to use them in our studies to show the first 
laboratory-controlled evidence that arsenic increases the severity of arterial occlusion 
indicative of atherosclerosis. In order to understand the mechanisms behind this 
occurrence, we looked at various components of atherogenesis that might be influenced 
by the presence of arsenic. Sodium arsenite, the reduced form of inorganic arsenic was 
used in these studies. We found that production of peroxynitrite, a strong oxidant formed 
from the coupling of nitric oxide and superoxide anion, is significantly increased in BAE 
cells exposed to sodium arsenite. In addition, the biological marker for peroxynitrite, 3- 
nitrotyrosine, is increased in the atherosclerotic plaque of arsenite treated ApoE^TLDLr'7' 
mice. Expression of the inflammatory mediator, cyclooxygenase-2 (COX-2) is also 
upregulated in response to arsenite exposure, indicating an increase in the inflammatory 
response in BAE cells. This result was supported by an increase in the generation of 
prostaglandin E2 (PGE2) following exposure to arsenite in BAE cells. There was also an 
increase in the synthesis of the COX-2 product, prostaglandin I2 (PGI2), in the serum of 
arsenite exposed mice, although we were unable to detect an increase in PGE2 in this 
model. Since peroxynitrite is capable of nitrating protein tyrosine residues, peroxynitrite 
formation can be confirmed by determining the extent of nitrotyrosine formation in a 
protein. Nitration of COX-2 was detected in arsenite-treated cells, but not in untreated 
control cells, supporting the evidence that an increase in peroxynitrite results from 
arsenite exposure in BAE cells. Furthermore, an increase in the proinflammatory protein 
5-lipoxygenase (5-Lo) results from arsenite exposure in BAE cells. This is mirrored by 
an increase in LTE4, a product of the 5-Lo pathway, in the serum of mice chronically 
exposed to arsenite as well as in BAE cells. The findings in this report show that arsenic 
definitively increases the severity of occluded arteries in atherogenic mice and suggests 
an increase in reactive species, notably peroxynitrite, in BAE cells exposed to arsenic. 
Furthermore, induction of important inflammatory mediators such as COX-2 and 5-Lo 
may exacerbate the inflammatory state typical of atherosclerosis.
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LITERATURE REVIEW 
Rationale
The focus of our lab is to develop a better understanding of the mechanisms 
behind arsenic-induced cardiovascular disease. This knowledge will aid in future 
prevention endeavors and treatment of people who are exposed to environmental 
contaminants that result in heart disease. The objective of these studies is to define the 
changes in the atherosclerotic lesions of ApoE'^/LDLr'7' mice and endothelial cell 
homeostasis in response to arsenic exposure that may result in initiation, onset or 
progression of atherosclerosis. We focus on the ability of arsenic to cause an oxidative 
and inflammatory environment within the endothelium that will result in an increase in 
CVD. To address these issues we use cultured endothelial cells as well as ApoE‘/7LDLr'/' 
mice susceptible to atherogenesis. This study is unique in that it progresses from the 
chemical changes resulting from arsenic exposure to a molecular and finally pathological 
outcome by using both in vitro and in vivo techniques.
Specific Aim 1: Define the changes in key atherogenic regulatory proteins upon 
exposure to arsenic in bovine aortic endothelial cells.
Specific Aim 2: Investigate the effects of arsenic on the formation of peroxynitrite 
in endothelial cells.
Specific Aim 3: Determine the effects of arsenic on atherogenesis and expression 
of key CVD regulatory molecules in the ApoE'^/LDLr7' atherosclerotic mouse model.
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Arsenic
Environmental Importance. Arsenic constitutes approximately 5 ppm of the 
earth’s crust with inorganic arsenic being the major type found in drinking water.
Arsenic is released into the environment through natural and manmade endeavors such as 
mining, smelting, and pesticide applications. Contamination “pockets” resulting from 
improper hazardous waste management, primarily from mining, has created an immense 
challenge for the United States and the Environmental Protection Agency (EPA). The 
western part of Montana, in particular, is home to the Clark Fork Complex, the largest 
group of superfund sites in the country (Moore and Luoma, 1990). The hazardous waste 
problem in this area was produced by more than 127 years of copper and silver mining 
and subsequent smelting activities. Typically, ore containing valuable mineral is 
separated by milling and flotation with as much as 90% being discarded as “tailings”. 
Subsequent refining processes result in flue dust and slag which can contain “thousands 
of times the natural levels of arsenic, cadmium, copper, lead and zinc”. In fact, the Clark 
Fork Complex could contain as much as 9,000 metric ton (MT) of arsenic, 200 MT of 
cadmium, 90,000 MT copper, 20,000 MT lead, 200 MT silver, and 50,000 MT zinc as 
deposits in tailings ponds.
Smelting is one of the most destructive stages in the mining process, resulting in 
3.7 x 106 MT of air pollutants per year in conjunction with the ground and water 
contamination (Moore and Luoma, 1990). Anaconda, Montana is an example of the 
damage caused by smelting techniques, where in 1902, cattle, sheep and horses started 
displaying signs of arsenic poisoning only months after a new copper smelter began
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production. In fact, it was due to the incidence of arsenic in the groundwater that the 
Milltown Reservoir Superfund Site (MRSS), near Milltown, Montana was established.
Located just outside of Missoula, Montana MRSS is an artifact of the Milltown 
Dam, built at the confluence of the Clark Fork and Blackfoot Rivers in 1907. Acting as a 
repository for sediment and mining wastes, the reservoir is highly contaminated and 
caused the formation of a groundwater arsenic plume that impacted Milltown's drinking 
water supply (USEPA). EPA added the site to its National Priorities List (NPL) in 
September 1983 and is addressing the problem through the combined actions of federal 
and state agencies and the Potentially Responsible Parties (PRPs), primarily the Atlantic 
Richfield Company (ARCO) and the Northwestern Energy Corporation.
In 1983, concern for the health of the Milltown residents resulted in an organized 
effort of volunteers to supply residences with water service on a biweekly basis for three 
months. In 1984, EPA provided replacement water for Milltown and in 1985, EPA 
replaced household water supply equipment that remained a source of contamination, as 
well as continued sampling of individual residences. However, the problem of the huge 
sediment deposit sitting behind the Milltown Dam remains an issue. Recently, the EPA 
has released a proposed plan for public review and comment which would result in 
removal of the dam as well as limited sediment removal. The potential benefits of this 
plan would be “permanent, long-term protection of public health and the environment, 
recovery of the Milltown drinking water aquifer, substantial elimination of contaminant 
release from ice-scouring and catastrophic events”, as well other environmental benefits 
such as the return of the Clark Fork and Blackfoot rivers to a free-flowing state and 
unrestricted fish passage (USEPA, 2003). The process of evaluating risk and developing
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recovery and management plans for the MRSS has lasted ten years and is still an ongoing 
process. Once a remediation plan has been established and a record of decision finalized, 
site preparation will begin. In the year 2006, removal of 2.6 million cubic yards of 
sediment will begin, a process that is expected to take three years. Under the proposed 
plan, the sediments would be relocated less than a mile downstream from the Dam in a 
lined repository. Finally, the dam would be removed in 2009 and stabilization and 
revegetation of the Clark Fork and Blackfoot channels would begin in 2010. The cleanup 
of the MRSS is estimated to cost $95 million!
Pesticide application is another source of man-made contamination of the 
environment by arsenic. Arsenic compounds have traditionally been used to control plant 
pests in cotton and grape crops (Gao and Burau, 1997). Arsenic can accumulate to 
phytotoxic levels in the soil after continuous use of arsenical pesticides and herbicides 
and then be released into the environment after transformation from microbial activity 
(Gao and Burau, 1997). This long-time practice has contributed to the overall 
environmental load of arsenic and its prevalence as a human health problem.
The oxidized form of arsenic, arsenate (As[V]), is the predominant species in 
water followed by arsenite (As[III]). Arsenate is reduced in vivo to arsenite (As[III]), 
which can be further metabolized to mono- and dimethylated derivatives (Abernathy et 
al., 1999). Arsenite is considered to be the most toxic form of inorganic arsenic (Buchet 
and Lison, 2000) and has been linked to a number of diseases, including bladder, lung 
and skin cancers, various cardiovascular diseases, hepatic and renal pathologies, diabetes 
and neuropathy (Szymanska-Chabowska et al., 2002).
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Toxicology. Arsenic is a known human carcinogen and has also been linked to 
other health effects such as hypertension, various vascular diseases, diabetes, and 
polyneuropathy (Chabowska et a l, 2002). In general, mechanisms of arsenic toxicity 
are attributed to its ability to uncouple oxidative phosphorylation by inhibition of succinic 
dehydrogenase and a-ketoglutarate dehydrogenase activity, interference with the 
regulation of stress proteins, and inhibition of enzymes critical for the cellular response to 
oxidative stress, such as thioredoxin reductase (Chabowska et al., 2002). However, the 
toxicity of arsenicals has been shown to be specific to the valency state of arsenic, tissue 
type, and species of animal affected (Fierro et al., 1999; Vahter, 2002).
It has been suggested that arsenic partially induces its toxic effect by the 
formation of reactive oxygen and nitrogen species (Liu and Jan, 2000). This is supported 
by studies demonstrating the cytoprotective effects of the antioxidant glutathione against 
trivalent arsenical-induced (arsenic trioxide and sodium arsenite) endothelial cell injury 
(Chang et al., 1991) and by the wide array of stress-induced heat shock proteins that are 
upregulated in response to arsenic exposure (Razo et al., 2001). For example, in bovine 
aortic endothelial (BAE) cells treated with sodium arsenite concentrations of 5 pM and 
above for 4 h, DNA. strand breaks (DSB) (including double-strand breaks, single-strand 
breaks, and alkali-labile sites) were significantly increased as detected by single-cell 
alkaline electrophoresis (Liu and Jan, 2000). This effect of DNA strand breakage was 
concentration dependent up to 20 pM arsenic. Reduction of DSB as a result of arsenic 
exposure was accomplished by the addition of superoxide dismutase as well as the NO 
synthase inhibitor, Nw-nitro-L-arginine methyl ester. Furthermore, addition of uric acid, 
a peroxynitrite scavenger resulted in fewer DSB (Liu and Jan, 2000). Similarly, porcine
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aortic endothelial cells (PAEC) treated with 5 pM arsenic (arsenic trioxide) had an 
increase in NF-kB dependent transcription as measured by luciferase expression as well 
as an increase in H^CVdependent tyrosine phosphorylation observed by immunoblots 
(Barchowsky et al, 1999). These effects were seen with a concurrent increase in reactive 
oxygen species generation as observed by EPR spectroscopy. These data suggest that 
low levels of oxidants generated in response to low concentrations of arsenic exposure 
may stimulate cell signaling and transcriptional activation (Barchowsky et al., 1999). 
Generation of reactive species in response to arsenic also results in an increase in lipid 
peroxidation that is inversely related to a depletion of cellular GSH (Ramos et al., 1995). 
This important observation was seen in liver, kidney tissue, and heart tissue (Ramos et 
al., 1995).
The carcinogenic effects of arsenic could be attributed to a wide range of possible 
mechanisms. Arsenic has been reported to cause chromosomal aberrations that may lead 
to cancer, including increased presence of micronuclei and sister chromatid exchanges 
(reviewed in Kitchin, 2001). Increased oxidative stress, altered growth factor synthesis, 
increased cell proliferation, and altered DNA repair are additional possible mechanisms 
involved in arsenic-induced carcinogenesis (Kitchin, 2001). One hypothesis regarding 
the mechanisms of arsenic carcinogenesis involves its ability to cause hypomethylation of 
DNA resulting in aberrant replication. This is supported by a study using the human 
colon cancer cell line, Caco-2. Caco-2 cells were treated with 0,1 or 2 pM arsenic 
followed by measurement of DNA methylation. Cells treated with 0 or 2 pM arsenic 
were significantly less methylated than cells treated with 1 pM arsenic. However, when 
methylation of the p53 tumor suppressor gene was accounted for singularly, cells treated
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with 2 pM, arsenic were significantly more hypomethylated than cells treated with 1 pM 
arsenic (Davis et al., 2000). These results suggest a wide discrepancy in the effects of 
arsenic toxicity depending on the concentration of exposure (Davis et al., 2000).
Arsenic may induce its cellular effects by modifying a variety of important factors 
necessary for normal function. In a study where mice received sodium arsenite in their 
drinking water for a period of 8  weeks there was a marked increases in AP-1 DNA 
binding activity at concentrations ranging from 20-100 pg/ml (Simeonova et al., 2001).
In mice that received 0.5-10 pg/ml there was a slight increase in AP-1 DNA binding 
activity, although it was not as striking as the higher dosage effects. In this same study, 
histopathological changes within the epithelial lining of the bladder were noted at arsenic 
concentrations between 50 and 100 pg/ml and included simple hyperplasia, and 
eosinophilic, cytoplasmic inclusions. The authors suggested a non-linear dose-response 
curve for predicting arsenic-induced bladder cancer that included the idea that lower 
concentrations of arsenic may cause cellular abnormalities that are not readily visible 
with histology (Simeonova et al., 2001). In a separate study, the human phospholipid 
hydroperoxide glutathione peroxidase (PHGPx) promoter was transfected into the human 
epidermoid carcinoma A431 cell line. There was a significant downregulation in the 
mRNA, protein expression, and enzyme activity of PHGPx after exposure to 30 pM 
arsenic for 9 h (Huang et al, 2002). A concomitant upregulation of the mRNA and 
protein expression of p21, a CDK inhibitor involved in the arrest of cells in the G1 phase, 
was also seen. These effects were significantly prevented by addition of the antioxidant 
N-acetyl-L-cysteine, suggesting that reactive oxygen species were involved in these 
processes (Huang et al., 2002).
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Although arsenic is well accepted as a carcinogen in humans, studies using rodent 
models have typically had limited success. However, a recent transplacental study done 
in mice demonstrated an increased incidence in the occurrence of hepatocellular 
carcinoma and adrenal tumors in male offspring with increases in ovarian tumors and 
cancers of the lung, uterus and oviduct in the female offspring as well (Waalkes et al, 
2003). In these animals exposure occurred through the dam during gestation only, 
suggesting that arsenic may have embryonic effects in rodents that had not previously 
been recognized. Furthermore, cellular events that have been linked to cancer in humans 
are being discovered in animal models. For example, low concentrations of arsenic (0.5- 
10 pM) were recently shown to cause an accumulation of low-molecular-weight protein 
conjugates that had been ubiquitinated in both rabbit renal-cortical slices and human 
embryonic kidney 293 cells (Kirkpatrick et al, 2003). This phenomenon could have an 
array of consequences on cellular signaling events that could lead to arsenic’s ability to 
cause cancer and cardiovascular disease.
Metabolism. Metabolism of arsenic in living systems usually involves a series of 
oxidation-reduction and methylation reactions (Scott et al, 1993). The oxidized form of 
arsenic, arsenate (AsV) is reduced to the more toxic inorganic form, arsenite (AsIII) via 
an As(III)-(GS)3 complex. Furthermore, glutathione complexes form subsequent to the 
reduction of arsenate and may be substrates for the methylating enzymes (Scott et al, 
1993). Inorganic arsenite and arsenate are metabolized by rat liver cytosol fractions 
through methylation using S-adenosylmethionine as the methyl group donor and reduced 
glutathione (Buchet and Lauwerys, 1988). The first methylation step, forming 
monomethylarsenite (MMA), is the rate-limiting step and may be catalyzed by GSH.
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There is a separate methylating enzyme responsible for further metabolism to the 
dimethylarsenite (DMA) form (Buchet and Lauwerys, 1988).
Human and rat hepatocytes exposed to trivalent inorganic arsenic at a concentration 
of 0.1 pM for 24-48 h had a peak intracellular arsenite concentration after exposure for 1 
h followed by a steady decline (Styblo et al, 1999). However, the cellular concentrations 
of methyl- and dimethylarsenite peaked after 9 and 24 h respectively. There was a steady 
decline in the inorganic arsenite concentration within the cell medium throughout the 
exposure period with MMA and DMA’s being undetectable for the first 6  h after 
exposure. Throughout the study, medium MMA contents increased only slightly and 
DMA concentrations rose steadily until it ultimately accounted for 60% of the total 
arsenic within the culture medium. In contrast, exposure to arsenate under identical 
experimental conditions resulted in less than 6 % of total arsenic being associated with 
cells (compared to as much as 30% with Arsenite) and the total methylation yield (both 
MMA and DMA’s) never exceeded 3% (Styblo et al., 1999). In addition, human 
fibroblast cells pre-exposed to arsenite developed an increased capacity for methylation 
when compared to cells having never been exposed to arsenite (Fischer et al., 1985).
In the rat, the liver has the greatest methylating capacity of all the organs. Arsenite 
enters the cells by diffusion and maintains its intracellular status by quickly binding to 
cellular components allowing extensive accumulation within the liver cells (Georis et al., 
1990). Glutathione plays a critical role by helping to facilitate the diffusion of arsenite 
into the cell, aiding in the primary methylation reaction and in the excretion of the 
secondary methylation product. In fact, agents that decrease the presence of hepatic 
glutathione also reduce the biliary excretion of both arsenite and arsenate (Gyurasics et
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al., 1991). In addition, arsenate is not extensively taken up by rat hepatocytes and is 
therefore poorly methylated (Georis et al., 1990). This may help explain the 
phenomenon seen in human liver, mice and rabbits where the in vivo methylation of 
arsenate requires a reduction step to the arsenite form (Vahter and Envall, 1983; 
Radabaugh and Aposhian, 2000). Inorganic arsenicals removed from the body through 
the bile are exclusively in the trivalent forms, either as arsenite or MMA (Gregus et al., 
2000). However, arsenic that is excreted through the urine is found in both the tri- and 
pentavalent form (Gregus et al., 2000).
There is a wide degree of variation between species in the rate of arsenic methylation 
(Wildfang et al., 1998). In one study purification of liver methyl transferases and 
subsequent activity assays showed a much higher degree of MMA formation in rabbits 
with a Vmax (pmol/mg protein/60 min) of 39.6 compared to 14.7 in the rhesus monkey 
and 0.022 in the hamster. In addition, MMA activity studies showed further 
discrepancies between species with the rhesus monkey having a higher capacity to form 
DMA with a Vmax of 21.5 than the rabbit with 4.01, followed by the hamster with 0.007 
(Wildfang et al, 1998). These results clearly show the differences that occur in the 
metabolism of arsenic within laboratory animals which may complicate comparisons with 
humans.
Mixtures. Elucidation of the mechanisms by which environmental contaminants 
exert their toxic effects is complicated by the fact that hazardous compounds are not 
found in the environment alone, but rather in conjunction with other compounds. The 
characteristics of the environment in which a toxicant such as arsenic is found may 
influence its solubility in water, bioavailability to plants and animals, rate of metabolism,
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and metabolic pathways. One potential mechanism for the wide diversity of cellular 
effects caused by arsenic is its ability to influence or be influenced by—other essential 
metals or toxicants. For example, DMA has been shown to significantly increase the 
release of iron from horse spleen ferritin (Ahmad et al., 2000). This remained true under 
both aerobic and anaerobic conditions and in the presence or absence of ascorbic acid, an 
agent known to aid in the absorption and release of iron (Ahmad et al., 2000). This is 
another pathway by which arsenic contributes to the oxidative state of an organism. 
Another metalloid, selenium, has been shown to influence the metabolism of arsenite 
(Csanaky and Zoltan, 2003). Selenium is an essential mineral, yet highly toxic if 
ingested in large quantities. The interaction between selenium and arsenite in biological 
systems has been well established and at times both metalloids counteract the toxic 
affects of the other (Gregus et al, 2000). In rats, tissue levels of MMA (III and V) were 
lowered by administration of selenium, while DMA levels were elevated (Csanaky and 
Zoltan, 2003).
Furthermore, it is possible that metals/metalloids influence each other indirectly 
through the generation of reactive intermediates. For example, we have shown that 
exposure to arsenic increases the synthesis of peroxynitrite, a highly reactive isomer of 
the nitrate anion linked with various pathological conditions (Bunderson et al., 2002). It 
is known that peroxynitrite influences the release of zinc from the zinc-thiolate cluster of 
endothelial NOS, forming disulfide bonds between the enzyme monomers and resulting 
in less NO synthesis(Zou et al., 2002). This has been related to increased generation of 
superoxide anion in diabetic mice and may also be important in the pathogenesis of 
atherosclerosis (Zou et al., 2002). Therefore, an increase in peroxynitrite in response to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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arsenic and arsenic mixtures would influence the normal functions of zinc and may 
contribute to atherogenesis. Finally, oral administration of inorganic arsenite to rats and 
guinea pigs has also been linked to an accumulation of copper in the kidneys, although 
the biological consequence of this interaction is unknown (Ademuyiwa and Elsenhans, 
2000).
Environmental contaminants other than metals may also influence the biological 
impact of arsenic. For example, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a 
common environmental pollutant resulting from application of contaminated pesticides. 
TCDD is a ligand for the aromatic hydrocarbon receptor and results in induction of both 
phase I and phase II detoxification enzymes. Arsenite has been shown to enhance 
TCDD-induced levels of nicotinamide adenine dinucleotide phosphate-quinone 
oxidoreductase (NQOl) mRNA in mouse hepatoma Hepa-1 cells (Maier et al., 2000). 
However, arsenite had no impact on the levels of the TCDD-inducible cytochrome P450, 
Cyplal, suggesting that studies on the effects of environmentally relevant mixtures may 
be complicated by imbalances in gene expression of important detoxification enzymes 
(Maier et al., 2000).
Cardiovascular Disease
Social Implications. According to most recent estimates by the American Heart 
Association, cardiovascular disease is the number one killer in the U.S. affecting 60 
million Americans with a resulting cost of 300 billion dollars a year.
Risk Factors. There are six risk factors that have been determined to be “causal 
and independent” through epidemiology, genetics, pathology and the result of clinical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
trials. These risk factors are as follows: cigarette smoking, elevated blood pressure, 
elevated serum low-density lipoprotein-cholesterol, low serum high-density lipoprotein- 
cholesterol, diabetes mellitus and advanced age (Frohlich and Lear, 2002). Other factors 
that are considered to be “predisposing” include: physical inactivity, obesity, abdominal 
density, family history of premature CAD, ethnic characteristics and psychosocial 
variables. Further “conditional” risk factors include elevated serum triglycerides, small 
LDL particles, elevated serum homocysteine, elevated serum lipoprotein (a), 
prothrombotic factors and inflammatory markers (Frohlich and Lear, 2002).
Four of the major risk factors for cardiovascular disease share a commonality in 
their ability to damage the cardiovascular system. Hypercholesterolemia, hypertension, 
diabetes, and cigarette smoking all contribute to a state of oxidative stress that has been 
linked to various forms of heart disease such as ischemia, stroke and myocardial 
infarction (Cooper et al., 2002). In addition, these four risk factors result in an 
accumulation of inflammatory and thrombogenic mediators that result in a pathological 
blood-vessel wall interaction resulting in enhanced pathogenesis (Cooper et al., 2002).
Recent studies suggest that people who are seropositive for Chlamydia 
pneumoniae (Cp) are at increased risk for developing atherosclerosis (Neumann, 2002).
In fact, Cp positive patients treated with the antibiotic roxithromycin showed a significant 
decrease in the progression of carotid occlusions. This is suggestive of yet another risk 
factor in the development of coronary artery disease (Sander et al., 2002), Furthermore, 
while there is a growing body of evidence linking exacerbation of atherosclerosis to 
certain bacterial and viral infections, several auto-antigens have been implicated in 
pathogenesis as well. Two of the most likely candidates for inducing an autoimmune
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response that result in an increase in the severity of cardiovascular disease are oxidized 
LDL and heat shock proteins (Greaves and Channon, 2002). There is also evidence 
suggesting that measuring intima media thickness (IMT) can predict an increased risk for 
future probability of CAD in persons with low-to-intermediate possibility of developing 
the disease (Sinha et al., 2002). The presence of arsenic in the drinking water has also 
been shown to be a contributing factor in the prevalence of cardiovascular disease (Wang 
et al, 2 0 0 2 ).
C-Reactive Protein (CRP) is a nonspecific marker for inflammation that has been 
correlated with the incidence of coronary heart disease and may also be an important risk 
factor (Pasceri et al, 2000). Addition of CRP to human umbilical vein and coronary 
artery endothelial cells resulted in an increase in the expression of VCAM-1 and ICAM-1 
after 24 h and a significant induction ofE-selectin after 6  h exposure. This effect was 
dependent on the presence of serum in the media. This study suggests that CRP may play 
a direct role in promoting the chronic inflammatory state characteristic of atherosclerosis 
(Pasceri et al., 2000).
Cyclooxygenase-2. Prostaglandins and other prostanoids are synthesized from 
arachidonic acid (AA) by prostaglandin endoperoxide H synthase, also known as 
cyclooxygenase (COX). AA is a polyunsaturated fatty acid that is released from 
membrane phospholipids through the activity of phospholipase A2 in response to 
chemical or mechanical stimuli (Smith and DeWitt, 1996). Following release of AA 
from cellular membranes, COX catalyzes its conversion to prostaglandin G2 (PGG2) 
through the addition of O2. PGG2 is an unstable compound and rapidly undergoes a two 
electron reduction forming PGH2. PGH2 is the stable precursor for all prostanoids.
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These compounds include the prostaglandins, prostacyclin (PGI2), and thromboxanes 
(TXA) and bind to G-protein-linked receptors resulting in altered second messenger 
synthesis (Smith and DeWitt, 1996).
There are two well-studied isozymes of the COX enzyme known as COX-1 and 
COX-2. COX-1 is considered to be the constitutive form of the enzyme and is found 
primarily in platelets, kidney, colon and stomach (Dannenberg and Zakim, 1999). It is 
known to be important in the normal physiological functions of prostaglandins such as 
regulation of renal blood flow and platelet aggregation (Lipsky et al., 2000). In contrast, 
COX-2 is undetectable in most tissues but is rapidly induced in response to cellular stress 
(Dannenberg and Zakim, 1999). COX-2 shares many characteristics of other stress 
response genes, including CCAAT/enhancer-binding protein, cyclic AMP-responsive 
element, pregnancy-specific protein-1 (Spl), and an NFkB site as regulatory mechanisms 
of its synthesis (reviewed in Fosslien, 2000). Products of the COX-2 pathway (Figure 1) 
have an affect primarily at the nuclear level and are typically involved in inflammation 
(Smith and DeWitt, 1996).
The role that cyclooygenase has in the development of atherosclerosis is currently 
a matter of debate. Under normal physiological conditions, prostaglandins serve as 
vasodilators or vasoconstrictors, depending on the compound and conditions, and are 
important for the onset of fever (reviewed in Campbell and Halushka, 1996). The various 
prostanoids are also known to increase glomerular filtration rate and renal blood flow as 
well as enhance sensitivity to pain endings and aid in fertilization (Campbell and 
Halushka, 1996). Perhaps the most important function of the prostaglandins with respect 
to cardiovascular disease is their role in inflammation. Aspirin, a nonsteroidal anti-
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Figure 1. Biosynthetic pathways of cyclooxygenase and 5-Lipoxygenase
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inflammatory inhibitor drug (NSAID) and nonspecific COX inhibitor, is associated with 
a reduction in mortality among individuals being evaluated for known or suspected 
coronary artery disease. Patients that benefited the most were elderly patients, those with 
impaired exercise tolerance, and individuals with a history of coronary artery disease 
(Gum et al, 2001). However, there is some concern that specific COX-2 inhibitors may 
contribute to the severity of atherosclerosis, probably by blocking PGI2 formation without 
influencing thromboxaneA2 (TXA2). This could result in increased platelet activation, 
adhesion, and aggregation thereby increasing the risk for future ischemic events.
5-Lipoxygenase. The lipoxygenases are a family of cytosolic enzymes similar to 
the cyclooxygenases that catalyze the oxygenation of AA and other polyenic fatty acids 
to lipid hydroperoxides (reviewed in Campbell and Halushka, 1996). AA is converted 
by the lipoxygenases to an unstable metabolite, hydroperoxyeicosatetraenoic acid 
(HPETE), which is then further metabolized to hydroxy fatty acids either 
nonenzymatically or by peroxidase activity (Campbell and Halushka, 1996).
Of particular interest is 5-lipoxygenase (5-Lo) and its biosynthetic products, the 
leukotrienes (Figure l)p. When cells are activated by increases in intracellular Ca**, 5- 
Lo translocates to the nucleus and associates with the 5-lipoxygenase activating protein 
(FLAP) resulting in activation of the enzyme (Campbell and Halushka, 1996). As a 
result, 5-HPETE is formed and rapidly converted to leukotriene A4 (LTA4 ) by leukotriene 
A synthase. Subsequent reactions lead to the various other leukotrienes, including LTB4 
and LTC4, D4, and E4 . The leukotrienes are primarily known for their role in asthma by 
causing bronchoconstriction through alterations of the airway smooth muscle cells and 
vascular endothelial cells (reviewed in Funk, 2001). The leukotrienes are also known to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
have an important part in inflammation. In fact, LTC4, D 4 , and E 4  are known to make up 
the material of “slow reacting substance of anaphylaxis” (Campbell and Halushka, 1996). 
There has only recently been evidence emerging that suggests the importance of the 5-Lo 
pathway in cardiovascular disease (Mehrabian et al., 2002). Although the mechanisms 
are mostly unknown, it is probably a combination of an enhanced state of inflammation 
and vasoconstriction.
Atherosclerosis. Atherosclerosis is the initial disease state that results in the 
manifestation of life threatening forms of cardiovascular disease, such as myocardial 
infarction and stroke. Current theories on the development of atherosclerosis underscore 
the pathology as a “process” that is first characterized by endothelial cell dysfunction, 
followed by the formation of foam cells due to uptake of oxidized lipoproteins by 
macrophages, proliferation of vascular smooth muscle cells, and exacerbation by the 
inflammatory process which may eventually lead to rupture of “vulnerable” plaque 
(Frohlich and Lear, 2002). Specifically, inflammatory conditions within the vasculature 
(such as ischemia/reperfusion) have been shown to be associated with adhesion of 
platelets to the vascular endothelium predisposing an individual to thrombosis and 
occlusion of the vasculature (Greaves and Channon, 2002). There are various 
inflammatory mediators that have been shown to be pro-atherogenic. These include 
various cytokines, chemokines and proteins including: IFN-7 , IL-18, CD40-CD154, 
MCP-1, IL-8 , IL-12, IL-1& LTB4 and 12/15 lipoxygenase products (Greaves and 
Channon, 2002). Although the endothelial lining that surrounds atherosclerotic plaque 
has very similar characteristics to that of activated endothelial cells, they lack the 
presence of recruited neutrophils typical of sites of acute inflammation. However, T-cells
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and monocytes are responsible for the expression of the vascular cell adhesion molecule- 
1 (VCAM-1) ligand—a protein that has been linked to the development of atherosclerotic 
plaque in genetically engineered mice (Greaves and Channon, 2002). The majority ofT 
cells found in atherosclerotic plaque are CD4+ which may have a distinct influence on 
the differentiation of monocytes into macrophages. However, the absence of an adaptive 
immune system does not confer total resistance to the development of atherosclerosis in 
mice suggesting other factors, such as oxidative stress, contribute to the mechanisms of 
disease development.
In addition to inflammation, oxidative stress has been implicated as another 
important player in atherogenesis. The primary manifestations of ROS on the 
microcirculation are increased inflammation and increased expression of adhesion 
molecules on the endothelium as well as circulating blood cells (Cooper et al, 2002).
This is significant due to the observation that both the endothelium and circulating blood 
cells can generate significant amounts of ROS under certain stimuli. It is further 
supported by the observation that exogenous addition of ROS results in increased 
leukocyte-endothelial cell adhesion which can be attenuated somewhat by the addition of 
antioxidants, (reviewed in Cooper et al, 2002). Human vascular endothelial cells that 
were induced into quiescence by inhibiting telomere function showed enhanced 
intercellular adhesion molecule-1 (ICAM-1) expression and decreased eNOS activity. 
These phenomena are both conditions that may contribute to atherogenesis (Minamino et 
al., 2 0 0 2 ).
Current Treatments. Recently, inflammation has been a therapeutic target for the 
treatment of atherosclerosis (Greaves and Channon, 2002). One class of cholesterol
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lowering agents, the statins, has been proven successful in primary and secondary 
treatment of CVD in several clinical trials. Statins decrease cholesterol biosynthesis by 
inhibiting the key enzyme HMG CoA reductase. The end result is not only a decrease in 
total plasma cholesterol but a concomitant increase in LDL receptor expression and an 
overall increase in plasma HDL cholesterol. Statin treatment is effective by increasing 
the stability of the atherosclerotic plaque rather than reducing the size or number present 
within the arterial wall. It has been suggested that statins may influence other aspects of 
atherogenesis in addition to influencing plasma cholesterol. Improved endothelial 
function, influences on NO synthesis, changes in smooth muscle cell proliferation and 
migration, disruption of MCP-1 production and leukocyte adhesion and rolling on 
endothelial cells have all been suggested as possible mechanisms by which statins 
influence atherogenesis . Pravastatin in particular has been shown to reduce C-Reactive 
Protein (CRP) levels, a systemic marker for inflammation, independently from its impact 
on serum cholesterol.
Treatments aimed at increasing overall HDL levels are another potential target for 
treatment of CVD. The protective effects of HDL are in part due to its ability to “reverse 
cholesterol transport” from the tissue into the blood then liver. However, the positive 
effects of HDL may also include effects on inflammation and oxidative stress by 
inhibiting endothelial-cell activation, maintaining NO-mediated endothelial function as 
well as transport of antioxidants (Greaves and Channon, 2002).
Inflammatory mediators, such as COX-2 and its products, the prostaglandins, 
have been used as a potential target for the treatment of cardiovascular disease.
However, there has been some concern that selective COX-2 inhibitors contribute to the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
severity of heart disease. This raises the question of whether COX-2 is an important 
player physiologically in cardiac performance or is a pathological component of 
atherosclerosis as previously assumed (Bertram et al, 2002). The primary concern is that 
COX-2 selective inhibitors block PGI2 formation without influencing thromboxaneA2 
(TXA2). This would result in increased platelet activation, adhesion, and aggregation 
thereby increasing the risk for future ischemic events. This theory was derived using 
PGI2 receptor (IP) and TXA2 receptor deficient mice. However, there is emerging 
evidence that COX-2 selective inhibitors have a beneficial effect on atherosclerosis, 
probably by decreasing inflammatory mediators within the vasculature. Support for this 
theory comes from LDLr /_ mice fed a western diet showing a reduction in atherosclerosis 
after treatment with rofecoxib. This occurred despite the ability of rofecoxib to inhibit 
PGI2 but not TXA2 production (Bertram et al., 2002). Aspirin, an NSAID and nonspecific 
COX inhibitor, is associated with a reduction in mortality among individuals being 
evaluated for known or suspected coronary artery disease. Patients that benefited the 
most were elderly patients, those with impaired exercise tolerance, and individuals with a 
history of coronary artery disease (Gum et al, 2001).
In addition to COX-2, a locus on mouse chromosome 6  that supplies almost total 
resistance to atherogenesis has been identified as the 5-lipoxygenase (5-Lo) gene 
(Mehrabian et al, 2002). This was determined using a congenic mouse strain designated 
CON6 that had a 5-fold reduction in 5-Lo niRNA. Furthermore, a 5-Lo knockout was 
bred onto an LDLr (-/-) background and heterozygous mice obtained. Both the CON6 
and the 5-Lo/LDLr (-/-) mice showed a significant decrease in aortic lesion development.
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This suggests that 5-Lo plays an important part in the process of atherogenesis and could 
be a potential therapeutic target (Mehrabian et al, 2002).
Angiotensin II appears to play an important role in the aggravation of 
atherosclerosis primarily by increasing oxidative stress, and activating the nonphagocytic 
NAD(P)H oxidases found on endothelial cell membranes (Schiffrin, 2002). Therapeutic 
use of Angiotensin II receptor antagonists has been shown to retard the progression of 
atherosclerosis (Schiffrin, 2002).
Arsenic and Cardiovascular Disease
Epidemiology. There are numerous epidemiological studies linking arsenic to the 
different forms of cardiovascular disease. In a long-term study in Taiwan, there was a 
significant association between cumulative arsenic consumption through artesian well 
water and prevalence of carotid atherosclerosis (Engel and Smith, 1994). The data was 
consistent regardless of the duration of exposure, the average arsenic concentration 
within the water, or cumulative arsenic exposure and remained significant after adjusting 
for known risk factors in the development of atherosclerosis (Engel and Smith, 1994).
In the United States, an investigation on the relationship between population- 
weighted mean arsenic concentration in public drinking water and death from 
cardiovascular diseases (CVD) in 30 U.S. counties showed an increase in the mortality 
ratio for various forms of CVD (Wang et al., 2002). These included diseases of the 
arteries, arterioles, and capillaries as well as an elevation in the incidence of 
arteriosclerosis and aortic aneurysm with a mean arsenic concentration greater than 2 0  
parts per billion (ppb). Furthermore, a cohort mortality study done in Millard County,
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Utah where the median drinking water arsenic concentrations ranged from 14 to 166 ppb, 
showed an increased mortality from hypertensive heart disease (Lewis, 1999).
In addition, Blackfoot Disease, a peripheral arterial disease confined to an area in 
southwestern Taiwan, is associated with exceedingly high-arsenic concentrations in 
artesian well water (Tseng et al., 1995). In this area, even seemingly normal individuals 
are observed to have abnormal microcirculation in the extremities (Tseng et al., 1995). 
More recently, individuals living in this arseniasis-hyperendemic region of Taiwan were 
examined for signs of ischemic heart disease (IHD) that may have been overlooked in 
previous studies on Blackfoot Disease (Tseng et al., 2003). The authors concluded that 
for those individuals with a cumulative arsenic exposure of 0.1-14.9 mg/l-year, there was 
an increased incidence between atherosclerosis and long-term arsenic exposure as 
diagnosed by electrocardiogram (Tseng et al., 2003). In addition to cardiovascular 
toxicities, arsenic exposure associated with the use of Fowler’s solution, a “health tonic” 
made up of potassium arsenite, has been linked to portal hypertension, a disease of the 
liver characterized by increased hepatic venous pressure (Viudez et al., 2 0 0 0 ).
Arsenic has also been implicated as an occupational hazard for pesticide 
applicators, primarily in vineyards. Exposure is by inhalation of contaminated fumes, 
dust or plant debris and ingestion of contaminated food and wine (Benowitz, 1992). 
Symptoms are primarily EKG abnormalities, ventricular tachycardia and red blood cell 
hemolysis (Benowitz, 1992). Recently, arsenic trioxide was approved for the treatment 
of acute promyelocytic leukemia. However, the side effects include cardiovascular 
toxicities such as prolongation of the QT interval and ventricular tachycardia (Li et al., 
2002; Ohnishi et al., 2000).
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Cellular mechanisms explaining the connection between arsenic and increased 
incidence of CVD are unknown. However, studies aimed at identifying involved 
pathways have demonstrated a link between arsenic and an increase in oxidative stress 
(Smith et al, 2001) and increases in inflammatory mediators (Liu et al., 2000), both of 
which are known contributors to the pathogenesis of atherosclerosis and other forms of 
CVD.
Oxidative Stress. Damage to the endothelial lining is one of the first steps in the 
onset of atherosclerosis. It has been suggested that arsenic contributes to endothelial 
dysfunction by initiating an increase in the synthesis of reactive oxygen species. In fact, 
arsenic has been shown to activate NAD(P)H oxidase on the membrane of vascular 
endothelial cells with as little as 5 pM sodium arsenite (Smith et al, 2001). In 
particular, stimulation of reactive oxygen species in vascular endothelial cells exposed to 
5 pM sodium arsenite or less was observed by electron paramagnetic resonance (EPR) 
spectroscopy (Barchowsky et al., 1999) and may be related to activation of the 
transcription factor NF-kB, a commom regulatory element in the promoter regions of 
many stress-induced genes (Barchowsky et al., 1996). Furthermore, a decrease in the 
expression of the Fas ligand (FasL), an important component of cytokine-induced 
leukocyte extravasation in endothelial cells exposed to 30 pM sodium arsenite, is 
dependent on an increase in the oxidative state of the cell (Tsai et al, 2 0 0 1 ).
In addition to induction of stress related genes, formation of superoxide anion as a 
result of membrane-bound oxidase activation provides an environment conducive for the 
formation of the extremely reactive nitrate isomer, peroxynitrite. The reaction between 
superoxide anion and nitric oxide is a nearly diffusion-limited reaction that occurs
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approximately three times faster than the scavenging of superoxide anion by superoxide 
dismutase (Beckman, 1996). The presence of peroxynitrite in a biological environment 
results in the nitration of tyrosine residues which can then be measured as a biological 
marker for peroxynitrite as 3-nitrotyrosine (3NY) (Crow and Ischiropoulos, 1996). In 
fact, atherosclerosis has been characterized by extensive nitration of protein tyrosine 
residues primarily within the atheroma, followed by foamy macrophage and nitration of 
the endothelium.(Beckmann et al., 1994). Our laboratory has demonstrated an increase 
in the synthesis of peroxynitrite in endothelial cells exposed to sodium arsenite, 
confirming a link between arsenic exposure and increased reactive oxygen and nitrogen 
species that could exacerbate atherosclerosis (Bunderson et al., 2002).
Generation of peroxynitrite as a result of arsenic exposure may have several 
cellular consequences important to the pathogenesis of atherosclerosis. Nitration of 
tyrosine residues has been shown to interfere with phosphorylation cascades necessary 
for proper signal transduction pathways. In fact, peroxynitrite-mediated nitration of a 
synthetic peptide resulted in a 51% inhibition of phosphorylation by protein tyrosine 
kinases (Gow et al., 1996). In addition to disrupting signal transduction pathways by 
interfering with protein phosphorylation, peroxynitrite has been shown to reduce the 
presence of soluble guanylate cyclase, the predominant intracellular nitric oxide receptor 
and a critical component in the formation of cGMP (Weber et al., 2001). This inhibitory 
effect of peroxynitrite may contribute to the oxidative stress associated with 
cardiovascular disease. The presence of ffee-3NY residues also results in severe 
consequences for the cardiovascular system. Rat aorta segments incubated with free- 
3NY resulted in a concentration-dependent impairment of acetylcholine-induced
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relaxation (Mihm et a l, 2000). This may be explained by the fact that 3NY is 
structurally similar to that of endogenous catecholamines (Figure 2) and therefore may 
serve as a competitive inhibitor (Kooy and Lewis, 1996). Furthermore, concentration- 
dependent DNA damage was observed with the TUNEL assay in rat aortic segments after 
incubation with 100 or 200 pM 3NY (Mihm et al., 2000).
An overall compromise in the efficiency of the cardiovascular system may also 
manifest itself as a result of increased peroxynitrite formation in response to arsenic 
exposure (Oyama et al., 1998). This was shown with an in vivo study using dogs to 
demonstrate an inverse relationship between left ventricular ejection fractions and the 
presence of myocardial 3NY residues (Oyama et al., 1998). The authors of this study 
hypothesized that peroxynitrite exerted its effects on the myocardium via IL-ljS.
One of the primary mechanisms by which arsenic may exert its influence on the 
exacerbation of atherosclerosis is through the generation of reactive species. Activation
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Figure 2. Chemical structures of L-Tyrosine, L-DOPA, and 3-nitro-L-Tyrosine
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of membrane-bound oxidases resulting in increased oxidative stress and the formation of 
peroxynitrite are likely the primary components involved.
Inflammation. The role of the immune system in the onset and progression of 
atherosclerosis has been well established (reviewed in Greaves and Channon, 2002). 
Changes in the normal expression of inflammatory mediators as well as the adaptive and 
innate immune system in response to arsenic exposure would have a broad impact on the 
development of the disease. In the kidney, chronic arsenic exposure of 22.5 parts per 
million (ppm) resulted in inflammatory cell filtration and inflammatory lesions with 
repeated exposures (Liu et al., 2000). Furthermore, histology from liver biopsy samples 
obtained from individuals in Guizhou, China with a history of exposure to environmental 
arsenic, showed liver lesions with chronic inflammation (Lu et al., 2001). Therefore, 
similar events in the cardiovascular system may occur as a result of arsenic exposure.
Cyclooxygenase-2 (COX-2), the nonconstitutive form of the cyclooxygenase 
enzymes, is a possible candidate for influencing the inflammatory state of atherosclerosis. 
Cyclooxygenase 1 (the constitutively expressed form) and 2 are homodimeric, heme- 
containing proteins responsible for the conversion of arachidonic acid to the various 
prostanoids (Smith et al., 1996). Despite having very similar homology, COX-1 and 
COX-2 are very different functionally. COX-1 is expressed primarily in platelets, colon, 
and stomach and serves in the cytoprotection of the gastric mucosa, regulation of renal 
blood flow and platelet aggregation (Lipsky et al., 2000). In contrast, COX-2 is typically 
undetectable in tissues other than kidney and brain unless induced in response to cellular 
stress, cytokines, oncogenes, tumor promoters and various growth factors (Lipsky et al., 
2000) and has been linked to ischemic heart disease in rats (Saito et al., 2000).
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Arsenic exposure to human fibroblast cells resulted in an increase in COX-2 
derived prostanoids, PGE2 and PGI2, at a concentration of 25 pM (Salzman and Bowman, 
1992) and COX-2 is upregulated in aortic endothelial cells at a concentration of 10 pM 
(Bunderson et al., 2002). In addition, when human umbilical vein endothelial cells 
(HUVEC) were exposed to arsenic there was a two-fold induction of the COX-2 protein 
resulting in a concomitant twofold increase in the synthesis of prostaglandin E2 (PGE2) 
(Tsai et al., 2002). This effect was attenuated by the addition of pyrrolidine 
dithiocarbamated (PDTC), an inhibitor of NFtcB, suggesting that arsenic may modulate 
its effects by activation of transcription factors involved in the stress response. This is a 
significant finding considering that an increase in the formation of proinflammatory 
prostanoids through induction of COX-2 contributes to experimental heart failure due to 
ischemic heart disease in rats (Saito et al., 2000).
The COX-2 protein has also been detected in atherosclerotic lesions, possibly 
promoting inflammation (Burleigh et al., 2002). Furthermore, addition of the specific 
COX-2 inhibitor, rofecoxib, and the nonspecific cyclooxygenase inhibitor indomethacin 
to male LDLr'A mice fed a western diet resulted in a significant reduction in the size of 
aortic plaque (Burleigh et al., 2002). In addition, platelets isolated from rats exposed to 
0,10, 25 or 50 pM arsenite for 60 min showed a significant increase in the percentage 
platelet aggregation observed versus saline controls (Lee et al., 2002). This phenomenon 
occurred simultaneously with an enhanced formation of TXA2, and expression of the 
adhesion molecule P-selectin (Lee et al., 2002). This is further evidence suggestive of an 
interference with activity of the cyclooxgenase pathways and inflammation upon 
exposure to arsenic.
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Recently, another inflammatory pathway closely related to the cyclooxygenase 
system has been recognized as an important component of atherogenesis. Mehrabian et 
al., (2 0 0 2 ), identified a locus on mouse chromosome 6  that confers almost total resistance 
to atherogenesis as the 5-lipoxygenase (5-Lo) gene. A dramatic decrease (>26-fold) in 
the development of aortic lesions was observed in 5-Lo knockout mice. The enzyme 5- 
Lo metabolizes arachidonic acid to leukotriene A4 (LTA4) which is then converted to 
leukotriene B4 (LTB4) and the cysteinyl-leukotrienes (C4, D4, and E4), all of which are 
known to have proinflammatory effects. Furthermore, Allen et al., (1998), demonstrated 
an LTC4 and LTD4-dependent state of hyperactivity in atherosclerotic coronary arteries 
suggesting an increase in the 5-Lo enzyme (Allen et al., 1998). Therefore, an increase in 
5-Lo expression or activity in response to arsenic exposure would have a dramatic impact 
on the severity of atherosclerosis.
Mouse Model
Available Models. In the past, studies intended to solve the mysteries of 
atherosclerosis were limited to primates and LDL-deficient rabbits (Pratico, 2001). 
However, mice have become more popular over recent years due to ease of breeding, 
prolific reproductive systems, availability of inbred strains, and techniques resulting in 
genetically altered strains (Pratico, 2001). There is a wide array of transgenic and 
knockout mice that have been utilized in the study of atherogenesis (Table 1) (Reue, 
2001).
One of the initiating events involved in atherosclerosis is the irreversible 
movement of apo B-containing lipoproteins within the vessel wall (reviewed in Sheth et
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Table 1. Genetically engineered mouse models for proteins in lipid metabolism
(Reue 2001, with permission)
Component Transgenic
Model
Knockout
Model
Apolipoproteins A-I + +
A-II + +
A-IV + +
B + +a
Cl + +
CH +
c m +
CIV +
E + +
Apo(a) + b
Lipoprotein
receptors
LDL receptor + +
LDL receptor-related protein +a
VLDL receptor +
ApoE receptor 2 +
Scavenger receptor + +
Lipoprotein 
remodel­
ing enzymes
Lipoprotein Lipase + +
Hepatic lipase + +
Cholesterol ester transfer protein + b
Lecithin cholesterol acyl transferase + +
A + in transgenic or knockout column indicates that an induced mutant mouse model 
hase been generated for the corresponding protein. 
aThe knockout model for this protein showed embryonic lethality 
bNot applicable; no mouse homolog exists.
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al, 2002). Therefore, mice capable of synthesizing only the Apolipoprotein B100 have 
been used to back cross with other types of atherogenic mouse models such as the low 
density lipoprotein (LDL) receptor null mice (LDLr'7') and the apolipoprotein E null 
mice (ApoE'7') (Sheth et al, 2002). Due to differences in the type of lipoproteins 
generated between these crosses, important characteristics of the atherogenic process 
were elucidated (Sheth et al., 2002). For example, using this system researchers were 
able to determine that cholesterol packaged in small LDL particles is more atherogenic 
than that packaged in very low density lipoprotein (VLDL) particles. In addition,
ABCA1 (Abcal'7') null mice characterized by a virtual lack ofhigh density lipoprotein 
(HDL) particles, as well as hepatic nuclear factor la-deficient (Hnfla'7') mice have been 
linked to problems with cholesterol metabolism and transport associated with 
atherosclerosis (Sheth et al., 2002). Studies using mice that are null for enzymes 
important in oxidative stress such as myeloperoxidase (Mpo'7'), which is involved in 
lipid oxidation and oxidative damage, and 12/15 lipoxygenase (12/15-Lo'7'), have 
demonstrated the importance of oxidation reactions in the pathogenesis of atherosclerosis 
(Sheth et al., 2002). Various other models have been used with varying degrees of 
success such as the immune deficient recombinase-activating genes 1 or 2  null mice 
(RAG lor 2 '7'), metalloproteinase deficient mice (Mmp3'7"), and vascular cell adhesion 
molecule-1 null mice (VCAM-1'7") (Sheth et al., 2002).
ApoE^/LDLrf~ mice. ApoE'7' mice are currently the most widely used model for 
the study of atherosclerosis due to spontaneous lesion development that closely resembles 
complex human atherosclerotic plaque (Reardon and Godfrey, 2001). ApoE is a 34 Kd 
glycoprotein that is produced predominantly by the liver, followed by various other
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tissues and macrophages (reviewed in Willems Van Dijk et al., 2000). There are three 
isoforms present in the human population including ApoE-III (most common), ApoE-IV, 
and ApoE-II. There is an increased incidence of dyslipidemia in healthy individuals who 
are positive for ApoE-H and IV, including decreased plasma LDL levels or elevated LDL 
levels, respectively, demonstrating a difference in the function of the different ApoE 
isoforms (Willems Van Dijk et al., 2000). ApoE is an important component in many 
steps ofVLDL metabolism, including VLDL-remnant clearance, VLDL-triglyceride 
production and VLDL-triglyceride lipolysis (Willems Van Dijk et al., 2000). As a result, 
ApoE deficient mice are extremely susceptible to hyperlipidemia and accumulation of 
VLDL resulting in spontaneous development of atherosclerosis similar to that seen in 
humans (Willems Van Dijk et al., 2000).
ApoE also serves an important function in the hepatic clearance ofVLDL 
remnants by acting as a ligand for the LDL receptor. Presence of the LDL receptor is 
critical for plasma clearance of lipoprotein remnants and in fact, overexpression of the 
receptor results in near normalization of the plasma lipid levels in mice with aberrant 
ApoE proteins (Willems Van Dijk et al., 2000). In general, LDLr'7' mice do not develop 
such severe or complex lesions as the ApoE'7' mice (Reardon and Godfrey, 2001). 
However, it is a useful model for studying the development of atherosclerosis especially 
when cross-bred with other genetically altered mice, such as the ApoE'7'. The ApoE'7' 
/LDLr'7' mice have accelerated plaque formation and develop severe occlusions relatively 
early in life. This makes them extremely useful for studying changes in atherogenesis in 
response to environmental toxicants.
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CHAPTER ONE
Arsenic Contributes to the Oxidative and Inflammatory State of Atherosclerosis by 
Increasing Peroxynitrite Formation and Cyclooxygenase-2 (COX-2) Expression
Abstract
Epidemiological evidence suggests that exposure to the metalloid arsenic 
constitutes a risk factor for cardiovascular disease. Some of the cardiovascular effects 
attributed to arsenic are decreased cardiac function, peripheral vascular diseases and 
atherosclerosis. The purpose of this study was to determine whether arsenic could 
contribute to the chronic inflammatory and oxidative stress symptoms characteristic of 
atherosclerosis, or coronary artery disease. We found that production of peroxynitrite, a 
strong oxidant formed from the coupling of nitric oxide and superoxide anion, was 
significantly increased in bovine aortic endothelial (BAE) cells exposed to sodium 
arsenite. Expression of the inflammatory mediator, cyclooxygenase-2 (COX-2) was also 
upregulated in response to exposure, indicating an increase in the inflammatory response 
in BAE cells. This result was supported by an increase in the generation of prostaglandin 
E2 (PGE2) following exposure to arsenic. Since peroxynitrite is capable of nitrating 
protein tyrosine residues, peroxynitrite formation can be confirmed by determining the 
extent of nitrotyrosine formation in a protein. For this experiment, COX-2 protein was 
immunoprecipitated from BAE cells and submitted to Western blot analysis using an 
antibody to nitrotyrosine. Nitration of COX-2 was detected in arsenic-treated cells, but 
not in untreated control cells. The findings in this report suggest an increase in reactive 
species, notably peroxynitrite, in BAE cells exposed to arsenic. Furthermore, induction of
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important inflammatory mediators such as COX-2 may exacerbate the inflammatory state 
typical of atherosclerosis.
Introduction
Human exposure to arsenic in drinking water has been linked to various 
cardiovascular diseases. In a comprehensive study involving 30 counties in the United 
States (Engel and Smith, 1994) an increased mortality ratio for cardiovascular disease 
was associated with a mean arsenic concentration in drinking water over 20 ppb. 
Mortality ratios were elevated for diseases of the arteries, arterioles, and capillaries 
including arteriosclerosis and aortic aneurysm. Furthermore, a cohort mortality study 
done in Millard County, Utah where the median drinking water arsenic concentrations 
ranged from 14 to 166 ppb, showed an increased mortality from hypertensive heart 
disease (Lewis et al., 1999). In addition, Blackfoot disease, a peripheral arterial disease 
confined to an area in southwestern Taiwan, is associated with exceedingly high-arsenic 
concentration in artesian well water (Tseng et al., 1995). In this area, even seemingly 
normal individuals are observed to have abnormal microcirculation in the extremities. 
Recently, arsenic trioxide was approved for the treatment of acute promyelocytic 
leukemia. However, the side effects include cardiovascular toxicities such as 
prolongation of the QT interval and ventricular tachycardia (Ohnishi et al., 2000). 
Identification of the mechanisms involved in arsenic-related cardiovascular diseases 
could lead to strategies for prevention or treatment of those diseases.
Inorganic arsenic is the major type found in drinking water, and the oxidized 
form, arsenate (As[VJ), is the predominant species. Arsenate is reduced in vivo to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
arsenite (As[IH]), which can be further metabolized to mono- and dimethylated 
derivatives (Abernathy et al., 1999). Arsenite is considered to be the most toxic form of 
arsenic (Buchet and Lison, 2000). The role of arsenic in cardiovascular disease is still 
largely unknown, but it may involve generation of oxidants in or near the vessel wall. 
Arsenic has been shown to activate an NAD(P)H oxidase found on the plasma membrane 
of vascular endothelial cells (Smith et al., 2001) and vascular smooth muscle cells (Lynn 
et al., 2000). Activation of these membrane-bound oxidases leads to increased production 
of reactive oxygen species, particularly superoxide anion (CV )• Superoxide anion 
combines with nitric oxide (NO ) to form an extremely reactive isomer of the nitrate 
anion, peroxynitrite. The reaction between superoxide anion and nitric oxide is a nearly 
diffusion-limited reaction that occurs approximately three times faster than the 
scavenging of superoxide anion by superoxide dismutase (Beckman, 1996). Peroxynitrite 
has been implicated in the oxidation of low-density lipoprotein (LDL) to a form 
recognizable by macrophage scavenger receptors, one of the putative first steps in 
atherogenesis (Keaney, 2000). Peroxynitrite has also been shown to decrease the 
antioxidant capacity within human blood plasma by oxidizing ascorbic acid, uric acid and 
plasma sulfhydryl groups (Van der Vliet et al., 1994). There is substantial evidence 
linking in vivo production of peroxynitrite with nitration of both free and protein bound 
tyrosine residues (Beckman, 1996). The presence of nitrotyrosine in biological samples 
has been used as a marker for the presence of peroxynitrite (Crow and Ischiropoulos, 
1996). In addition, nitrotyrosine residues have been observed using immunodetection 
techniques in various pathological conditions, including myocardial ischemia and 
atherosclerosis (Beckman and Koppenol, 1996). Atherosclerosis is characterized by a
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general, and in some cases marked, increase in the occurrence of nitrotyrosine residues 
(Beckmann et al, 1994; Leeuwenburgh et al, 1997).
Arsenic may also contribute to atherogenesis by increasing the inflammatory 
response. Cyclooxygenase-2 (COX-2) is the inducible form of a biphasic enzyme 
responsible for catalyzing the conversion of arachidonic acid to prostaglandin H2 (PGH2). 
PGH2 is converted to other prostanoids, including PGE2. The prostanoids are potent 
mediators of the inflammatory response and increase vascular permeability. COX-2 is 
found in macrophages, vascular endothelial cells and vascular smooth muscle cells (Sait 
et al, 2000) COX-2 is rapidly induced in macrophages and endothelial cells by 
proinflammatory cytokines and may be responsible for the edema and vasodilation 
associated with inflammation (Lipsky et al., 2000). COX-2 is induced under conditions 
of oxidative stress (Marrogi et al, 2000; Kumagai et al, 2000), and it has been suggested 
that eicosanoids produced by COX-2 contribute to oxidative stress (Nikolic and van 
Breemen, 2001). Since atherosclerosis is a chronic inflammatory condition (Lusis,
2000), it is likely that COX-2 is involved in the formation of atherosclerotic plaques.
The mechanisms and regulatory pathways involved in arsenic-induced 
cardiovascular disease are largely unknown. The purpose of this study was to determine 
whether arsenic could stimulate generation of factors involved in oxidative stress and 
inflammation, conditions associated with atherosclerosis, or coronary artery disease. In 
this paper we report that arsenic exposure increases production of an important oxidant, 
peroxynitrite, to cause the formation of nitrotyrosine residues and increased expression of 
a key inflammatory regulator, COX-2.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
Methods
Chemicals. Peroxynitrite was synthesized according to the method described by 
Uppu and Pryor (1996). Sodium arsenite was purchased from GFS Chemicals 
(Columbus, OH), hydroethidine was obtained from Polysciences, Inc. (Warrington, PA), 
and IGEPAL CA-63Q was purchased from Sigma (St. Louis, MO). Protease inhibitor 
cocktail tablets were purchased from Boehringer Mannheim (Mannheim, Germany). 
Superoxide dismutase and catalase were obtained from Fisher Scientific (Pittsburgh, PA). 
Nitrotyrosine antibody was obtained from Zymed, Inc. (San Francisco, CA), and the 
antimouse secondary was purchased from Jackson ImmunoResearch Laboratories, Inc. 
(West Grove, PA). COX-2 antibody was obtained from Santa Cruz Biotechnology, Inc. 
(Santa Cruz, CA), and the antirabbit secondary was purchased from Vector Laboratories, 
Inc. (Burlingame, CA). Actin antibody kit was obtained from Oncogene Research 
Products (Boston, MA). PGE2 enzyme immunoassay (ELISA) was obtained from 
Cayman Chemical (Ann Arbor, MI). All reagents were at least analytical grade.
Cell Culture. Bovine aortic endothelial cells (BAE), originally a gift from Dr. 
Steve Schwartz of the University of Washington, were provided by Dr. J. Douglas Coffin 
of The University of Montana Department of Pharmaceutical Sciences. Cell culture 
components were obtained from Life Technologies, Inc. (Rockville, MD) unless 
otherwise noted. BAE cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
with penicillin/streptomycin and L-glutamine, and supplemented with 15% fetal bovine 
serum (HyClone Laboratories, Inc., Logan, UT). The cells were incubated at 37 °C under 
a humidified atmosphere containing 5% CO2 . BAE cells were used between passage #’s 
2-6.
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Cell viability assay. Cell viability was determined using an adaption of the MTT 
colorimetric assay (Mosmann, 1983). Cells were plated in 96-well plates at a density of 1 
to 2 x 104 cells/mL and allowed to attach overnight (16 h). Sodium arsenite and sodium 
arsenate were applied in medium for 1 h. Arsenic solutions were removed and replaced 
with medium alone, and the 96-well plates were incubated for 5-7 days. MTT (50 pg) 
was added to each well, and the cells were incubated for another 4 h. Medium/MTT 
solutions were removed carefully by aspiration, the MTT formazan crystals were 
dissolved in 100 pi DMSO, and absorbance was determined on a plate reader at 550 nm. 
Cell viability was plotted as percentage of control vs concentration. Cell viability was 
also determined for hydroethidine, l-NAME, and DPI using this assay.
Fluorimetric Determination o f Peroxynitrite. To quantify peroxynitrite formation, 
we developed an assay based on the oxidation of hydroethidine. Hydroethidine is 
selectively oxidized to its fluorescent form, ethidium, by superoxide anion, hydrogen 
peroxide and peroxynitrite (Supinski et al., 1999; Al-Mehdi et al., 1997). This assay uses 
superoxide dismutase and catalase to remove extracellular superoxide and hydrogen 
peroxide, leaving peroxynitrite as the principal oxidant. BAE cells were grown to 
approximately 90% confluency then trypsinized (0.05% trypsin) and centrifuged at 2500 
x g. The supernatant was removed and cells resuspended in phosphate-buffered saline 
(pH=7.2) containing 0, 5, 10, or 20 pM sodium arsenite. Cell numbers were calculated 
using a hemacytometer. Cells were allowed to incubate in a 37° C water bath for 30 min. 
At the end of the incubation period, 2 mL of the solution was added to a cuvette 
containing 25 U each of catalase and superoxide dismutase. Prior to starting each 
experiment, 40 pM hydroethidine was added to the cuvette. The samples were run on an
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F-2000 Hitachi Fluorescence Spectrophotometer equipped with an automatic cuvette 
stirrer. Fluorescence was measured at 465 nm excitation and 585 nm emission over a 15 
min interval. Peroxynitrite formation was calculated based on a standard curve generated 
by adding known concentrations of peroxynitrite to phosphate-buffered saline at timed 
intervals.
COX-2 Immunoblot. BAE cells were grown to approximately 90% confluency 
and treated with sodium arsenite in concentrations of 0, 5,10 and 20 pM for 30 min.
Cells were harvested with 2X Laemmli buffer, homogenized with an 18 then 25 gauge 
needle and boiled for 5 min. Protein concentrations were determined by a Bradford assay 
(Biorad, Hercules, CA), and samples (5 pg) were loaded onto a 10% SDS gel. After 
protein separation, the samples were transferred to a polyvinylidenedifluoride (PVDF) 
membrane and probed for COX-2 protein using a rabbit polyclonal COX-2 antibody and 
an antirabbit secondary antibody conjugated with horseradish peroxidase. COX-2 was 
visualized by enhanced chemiluminescence (ECL; Amersham, Buckinghamshire, 
England). In separate experiments, BAE cells were exposed to 20 pM sodium arsenite for 
0, 0.5,1,12, 24 and 48 h to determine the effect of time on COX-2 expression. Blots 
were processed as detailed above.
COX-2 Immunoprecipitation. BAE cells were grown to near confluency and 
treated with sodium arsenite in concentrations of 0, 5,10 and 20 pM for 30 min. Samples 
were solubilized in a buffer containing 50 mM tris, 1 mM ethylenedieaminetetraacetic 
acid (EDTA), 0.1 mM butylated hydroxytoluene and a protease inhibitor cocktail tablet 
(pH=7.4). Cell lysates were sonicated and centrifuged at 12,000 x g for 1 h. Supernatant 
was collected and a final sample volume of 1 mL was attained with a buffer containing 1
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mM phenylmethylsulfonyl fluoride, 150 mM NaCl, 5 mM EDTA and 0.5% IGEPAL 
CA-630 (pH= 8.0). Protein was assayed as before and samples equalized for protein 
content. Protein A sepharose CL-4B was used to preclear the solubilized protein and the 
samples were then centrifuged at 14,000 x g for 5 min and the supernatant collected. A 
polyclonal anti-COX-2 antibody (10 pg) was used to precipitate the precleared protein 
for 18 h at 4°C. Immune complexes were then precipitated with 50 pL protein A CL-4B 
for 2 h. The precipitate was washed three times with 0.5 mL SINTE (0.5% sucrose, 1% 
IGEPAL CA-630, 0.5 M NaCl, 50 mM tris, 5 mM EDTA; pH=7.4) followed by 
centrifugation. Samples were resuspended in 50 pL 2X Laemmli sample buffer and 
heated at 95°C for 5 min. Samples were run on a 10% tris-polyacrylamide gel at 150 V 
for 75 min and the protein transferred onto a PVDF membrane at 90 V for 1 h. The 
immunoblot was developed in the same manner as the COX-2 Western blots, substituting 
a mouse monoclonal antinitrotyrosine antibody and an antimouse secondary antibody.
Prostaglandin E2 Enzyme Immunoassay (ELISA). A PGE2 ELISA kit was used 
according to manufacturer’s instructions. BAE cells were incubated for 45 min with 
sodium arsenite (0,10 and 20 pM). The media was collected and centrifuged at 2500 rpm 
for 5 min. The centrifuged media was added directly to the ELISA plate as directed. Data 
were analyzed by using a standard curve generated by plotting the percent bound divided 
by the maximum binding versus the log of PGE2 concentrations.
Results
Cell viability was assessed using a variation of the MTT colorimetric assay 
(Mosmann, 1983) that is based on the conversion of MTT to purple formazan crystals by
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viable cells (Figure 3). As expected, sodium arsenite was more toxic to BAE cells than 
sodium arsenate after 1 h exposures at various concentrations. IC50 values (concentration 
at which cell survival equals 50% of control) were 54.2 +/- 8.6 pM for sodium arsenate. 
Concentrations of sodium arsenite used in subsequent experiments did not exceed 20 pM.
Peroxynitrite, the coupling product of nitric oxide and superoxide anion, is an 
oxidant that has been implicated in atherogenesis. Our approach to quantifying 
peroxynitrite formation in BAE cells was to first look for general evidence of oxidant 
production and then to use antioxidant enzymes, a general NOS inhibitor, and an oxidase 
inhibitor to identify peroxynitrite as the principal oxidant. Oxidant production was 
determined fluorimetrically by measuring the oxidation of hydroethidine to its fluorescent 
form, ethidium. Hydroethidine is preferentially oxidized by superoxide anion, hydrogen 
peroxide, and peroxynitrite (Supinski et al., 1999; Al-Mehdi et al., 1997). Total reactive 
species increased in a dose-dependent maimer up to 10 pM sodium arsenite (Figure 4). 
Addition of SOD and CAT had little effect on levels of reactive species (Figure 5A), 
suggesting either that peroxynitrite was the principal oxidant generated in endothelial 
cells by sodium arsenite or that all of the superoxide anion and hydrogen peroxide were 
produced intracellularly, where added SOD and CAT would have no effect. The latter 
scenario seems unlikely since most superoxide generation in endothelial cells is 
associated with plasma membrane NAD(P)H oxidases (Barchowsky et al., 1999; Smith 
and DeWitt, 1996) the general NOS inhibitor L-NAME (Figure 5B) or the NAD(P)H 
oxidase inhibitor DPI (Figure 5C) reduced fluorescence to control levels, confirming that 
peroxynitrite is primarily responsible for the fluorescence observed in arsenic-treated 
cells. Cell viability studies showed no toxicity to BAE cells treated with hydroethidine,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
54
DPI, or L-NAME at the concentrations and times used in these experiments (data not 
shown).
The synthesis of prostaglandins by the COX isozymes is a necessary event in 
normal vascular physiology and the inducible form, COX-2, is a key player in 
inflammation. Since atherosclerosis is an inflammatory disease, we reasoned that COX-2 
might play an important role in arsenic-induced atherogenesis. Expression of COX-2 
protein was measured by Western blot analysis using a polyclonal COX-2 antibody and 
chemiluminescence. The data show that COX-2 protein was increased after 30 min 
exposure to 5,10, and 20 pM arsenite (Figure 6a-b). Furthermore, COX-2 induction was 
time dependent, showing a decline up to 24 h and then increasing again at 48 h (Figure 
7a-b). Densitometry using COX-2/actin ratios showed a twofold increase in COX-2 
protein at 20 min and an over threefold increase after 48 h. No increase in COX-2 
protein was observed at sodium arsenite concentrations less than 5 pM (not shown). The 
presence of multiple bands is a common occurrence due to post-translational 
modification of COX-2 (Smith and DeWitt, 1996).
Immunoprecipitation was used to confirm the formation of peroxynitrite and to 
determine the extent of COX-2 nitration upon arsenic exposure. COX-2 was 
immunoprecipitated from endothelial cells that were treated for 30 min with 5,10 and 20 
pM sodium arsenite. Western blots were then probed with an antinitrotyrosine antibody. 
Nitrated COX-2 was observed in cells treated with all concentrations of sodium arsenite, 
whereas there was no evidence for nitration of COX-2 in the non-arsenic-treated cells. 
(Figure 8).
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Figure 3. Cell viability for BAE cells treated with up to 500 pM sodium arsenate
(As[V]) or sodium arsenite (As[III]) for 1 h.
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Figure 3. Cell viability for BAE cells treated with up to 500 pM sodium arsenate (As[V]) 
or sodium arsenite (As[IH]) for 1 h. Viability was measured using an adaptation of the 
MTT colorimetric assay as described under Methods. Viability is expressed as 
percentage of control (untreated cells); error bars represent mean +/- SD for n = 3 
experiments.
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Figure 4. Total oxidant formation in BAE cells treated with sodium arsenite
(As [III]) at 0,0.25,0.5,1,5, or 10 fiM for 1 h.
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Figure 4. Total oxidant formation in BAE cells treated with sodium arsenite (As[III]) at 
0,0.25,0.5,1,5, or 10 pM for 1 h. This assay is based on the oxidation of hydroethidine 
(40 pM) to its fluorescent product, ethidium (see Methods). * Significantly different from 
control, p<0.01. Error bars represent the mean +/- SD for n = 3 experiments.
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Figure 5. Peroxynitrite formation in BAE cells treated with sodium arsenite
(As [III]) at 0,0.25,0.5,1,5, or 10 jiM for 1 h.
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Figure 5. Peroxynitrite formation in BAE cells treated with sodium arsenite (As[HI]) at 0, 
0.25, 0.5,1, 5, or 10 pM for 1 h. Same assay as in Fig. 3, except that 25 U/mL each of 
SOD and CAT was added with the hydroethidine. (A) No inhibitor was added to the 
BAE cells prior to sodium arsenite treatment. (B) General NOS inhibitor, L-NAME (30 
pM), was added to the BAE cells 1 h prior to sodium arsenite treatment. (C) NAD(P)H 
oxidase inhibitor, DPI (10 pM), was added to the BAE cells with sodium arsenite 
treatement. * Significantly different from control, p<0.05. **Significantly different from 
control, p<0.01. Error bars represent the mean +/- SD for n = 3 experiments.
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ELISA was used to measure the formation of COX-derived PGE2 in endothelial cells 
following exposure to arsenic. Cells treated with 10 and 20 pM arsenite for 45 min 
showed a 14% and 80% increase, respectively, in the formation of PGE2 compared to 
control cells (Figure 9). These data corroborate the COX-2 protein expression findings 
and suggest that arsenic may contribute to atherogenesis through the COX-2 pathway.
Discussion
Atherosclerosis is a chronic inflammatory disease exacerbated by oxidative stress. 
Under conditions of stress, oxidation of LDL and subsequent phagocytosis by 
macrophages leads to the formation of foam cells. These “fatty” macrophage cells die, 
leaving behind a growing mass of extracellular debris (Lusis, 2000). This will eventually 
cause arterial occlusion and disease. An increase in oxidative stress in response to arsenic 
exposure may contribute to atherosclerosis in various ways. Cytokines (Fong et al, 2000) 
and oxidative stimuli (Fang et al., 2000) can result in the upregulation of the inducible 
COX-2 enzyme and contribute to the inflammatory status of atherosclerosis. The 
formation of reactive nitrogen species seems to play a particularly important role, either 
by direct oxidation of LDL (Keaney, 2000), induction of inflammatory mediators 
(Gerszten et al, 2000), alterations of protein conformation via tyrosine nitration (Gow et 
al, 1996) or possibly through signaling pathways responsive to molecules such as 
peroxynitrite (Levonen et al., 2001). In the case of arsenic exposure, formation of 
peroxynitrite as well as an increase in the inflammatory response could be contributing 
factors in the aggravation of arsenic-related cardiovascular disease. In the present study, a 
rise in peroxynitrite production was observed in arsenic-treated endothelial cells along
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with an increase in expression of COX-2. This was accompanied by elevated levels of a 
PGE2, a key eicosanoid product of COX-2 and detection of 3NY residues in COX-2.
The induction of COX-2 in response to arsenic exposure is a dynamic cellular 
event that is time dependent. The present results show that COX-2 protein expression 
increases within the first 30 min then declines over the next 24 h with continuous arsenic 
exposure. A significant increase in the production of PGE2 at 45 min following exposure 
to arsenic was also observed. After 48 hours of exposure there is a second peak in the 
COX-2 protein. The time course of COX-2 induction may be important in both the onset 
and the resolution of inflammation. During an inflammatory response, induction of COX- 
2 converts the PGD2 dominated prostaglandin synthesis seen in quiescent cells to the 
proinflammatory mediator PGE2 (Colville-Nash and Gilroy, 2000). After the first 30 min, 
this event is followed by a return to PGD2 synthesis and induction of anti-inflammatory 
stress proteins such as heat shock protein 70 (HSP70) and heme oxygenase-1 (HO-1). In 
agreement with the current data, the authors of this earlier report also observed a second 
peak in COX-2 expression at 48 h following injection of an irritant in mice (Colville- 
Nash and Gilroy, 2000). A recent study by Tsai et al. (2002) reported increased COX-2 
expression and PGE2 generation in human umbilical vein endothelial cells (HUVECs) 
following exposure to sodium arsenite. They showed that PGE2 was elevated twofold in 
HUVECs after 15 h of sodium arsenite treatment (Tsai et al. 2002), suggesting a 
proinflammatory state at this time point.
The present results show that increased production of peroxynitrite occurs within 
30 min following arsenic application, correlating to both the initial COX-2 induction and 
the increase in prostaglandin synthesis. The involvement of peroxynitrite in arsenic-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
63
Figure 6. COX-2 Western blots of BAE cells treated with sodium arsenite.
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Figure 6. COX-2 Western blots of BAE cells treated with sodium arsenite. Cell lysates 
were run on a polyacrylamide gel and transferred to a PVDF membrane and probed with 
a polyclonal anti-COX-2 antibody. Sample loading was controlled by probing the same 
membrane with an anti-actin antibody. Each blot is representative of two independent 
experiments. COX-2 positive control was from RAW 264.7 murine macrophages. (A) 
Cells were treated with 0, 5,10 or 20 pM sodium arsenite (As) for 30 min. (B) Ratio 
between densitometry of COX-2 and actin bands from blot in (A).
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Figure 7. COX-2 Western blots of BAE cells treated with sodium arsenite
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Figure 7. COX-2 Western blots of BAE cells treated with sodium arsenite. Cell lysates 
were run on a polyacrylamide gel and transferred to a PVDF membrane and probed with 
a polyclonal anti-COX-2 antibody. Sample loading was controlled by probing the same 
membrane with an anti-actin antibody. Each blot is representative of two independent 
experiments. COX-2 positive control was from RAW 264.7 murine macrophages. (A) 
Cells were treated with 0, 5,10 or 20 pM sodium arsenite (As) for 30 min. (B) Ratio 
between densitometry of COX-2 and actin bands from blot in (A).
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Figure 8. Nitrotyrosine Western blot from COX-2 immunoprecipitations of BAE
cells treated with sodium arsenite (As) at 0,5,10 or 20 pM for 30 min.
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Figure 8. Nitrotyrosine Western blot from COX-2 immunoprecipitations ofBAE cells 
treated with sodium arsenite (As) at 0, 5,10 or 20 pM for 30 min. Cell lysates were 
immunoprecipitated with a COX-2 polyclonal antibody and the samples loaded on a 
polyacrylamide gel, transferred to a PVDF membrane, then probed with a monoclonal 
anti-nitrotyrosine antibody. COX-2 positive control was from RAW 264.7 murine 
macrophages and was not nitrated. Bovine serum albumin (BSA) positive control was 
nitrated. Representative blot from two independent experiments. (B) Densitometry on 
immunoblot in (A).
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Figure 9. PGE2 formation in BAE cells exposed to sodium arsenite
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Figure 9. PGE2 formation in BAE cells exposed to sodium arsenite (As) at 0,10 or 20 
pM for 45 min. Data were generated using a PGE2 ELISA. Results are from two 
independent experiments run on two different ELISA plates. Treatment groups marked 
with an asterisk (*) are significantly different from the controls (p<0.05). Error bars 
represent the mean +/- standard deviation for n=4 samples.
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induced toxicity is supported by the work of Gurr et al. (1998). They found that increases 
in intracellular oxidant levels due to arsenic were inhibited by NO synthase inhibitors, but 
not by catalase inhibitors. They also reported that formation of arsenic-induced 
micronuclei was reduced by NO synthase inhibitors, superoxide dismutase and uric acid 
(Gurr et al., 1998). Liu and Jan (2000) demonstrated increases in nitrite levels and DNA 
strand breaks in BAE cells, again only at arsenic concentrations of 5 pM or more.
Peroxynitrite has been shown to be a substrate for the peroxidase activity of 
COX-2, and this leads to activation of the enzyme (Landino et al., 1996). In the current 
study, we showed that arsenic exposure and the subsequent formation of peroxynitrite 
leads to increased nitration of COX-2 tyrosine residues. Although peroxynitrite is an 
important nitrating compound, it is not the only reactive nitrogen species capable of 
tyrosine nitration (Ischiropoulos, 1998). In fact, there is evidence that COX-2 can be 
nitrated by a pathway that begins with nitric oxide reacting with a tyrosyl radical to form 
nitrosotyrosine. This intermediate can be oxidized to nitrotyrosine (Ischiropoulos, 1998). 
Therefore, we cannot rule out the possibility that nitrating species other than peroxynitrite 
may be involved. Nitration of tyrosine residues within the COX-2 protein has been 
shown to decrease enzyme activity (Boulos et al., 2000), although the net effect of 
increased substrate and decreased activity is unknown.
It has been suggested that reactive nitrogen species may function as signal 
transduction molecules (Levonen et al., 2001). In contrast, peroxynitrite may cause 
protein nitration that prevents phosphorylation and could target the proteins for 
degradative pathways (Gow et al., 1996). Perhaps after an acute arsenic exposure, the 
oxidative insult to the cell activates an inflammatory response by inducing the COX-2
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enzyme and providing it with an initial substrate (e.g. peroxynitrite). This response could 
then be “turned off’ by nitration of the enzyme, decreasing its activity and possibly 
making it more susceptible to degradation. This may then allow the cell to upregulate the 
necessary anti-inflammatory mediators needed for resolution, such as HSP70 and HO-1. 
In chronic arsenic exposure, our data showing a second increase in COX-2 protein at 48 h 
may be more relevant, but more work is clearly needed in this area.
COX-2 may also play a role in the upregulation of renin, adversely affecting 
blood pressure homeostasis (Lipsky et al, 2000) and exacerbating cardiovascular disease. 
Furthermore, COX-2 overexpressing cells demonstrate an increase in endothelial 
migration (Tsujii et al., 1998). This may contribute to atherosclerosis by enhancing 
angiogenesis thereby providing an entry site for inflammatory cells ( Lusis, 2000) and 
exacerbating plaque formation.
Our data showing an increase in reactive nitrogen species and corresponding 
increase in the inflammatory response suggest one way that arsenic may contribute to 
atherosclerosis. However, these phenomena may also contribute to other forms of 
cardiovascular disease. Cheng et al. (1999) demonstrated that myocardial dysfunction 
induced by the inflammatory mediator, IL-1 (3, was significantly diminished by both an 
inducible nitric oxide synthase inhibitor and a novel inhibitor of superoxide anion 
production. This suggests that peroxynitrite may not only contribute to atherosclerosis, 
but to cytokine-induced myocardial dysfunction as well. Furthermore, administration of 
the superoxide anion inhibitor abolished formation of nitrotyrosine residues within the 
myocardium (Cheng et al., 1999). In addition, it has been shown that there is an inverse 
relationship between myocardial nitrotyrosine concentrations and left ventricular ejection
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fractions in dogs (Oyama et al., 1998). Treatment of cardiac myocytes with peroxynitrite 
results in an influx of extracellular calcium ions with a concomitant decline in cellular 
activity. The authors suggested that this decreased sensitivity to calcium was due to 
nitration of contractile proteins (Ishida et al., 1996).
Arsenic exposure leading to generation of reactive nitrogen species along with an 
increase in inflammatory mediators may provide an environment conducive to the onset 
and progression of atherosclerosis. Peroxynitrite’s impact on cell signaling, protein 
function, and modifications should be investigated further. Also, the impact of arsenic 
exposure on other inflammatory mediators that may influence the onset and progression 
of atherosclerosis needs to be addressed.
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CHAPTER TWO
Exacerbation of Atherosclerotic Plaque and Increased Nitrotyrosine Formation in 
Response to Arsenic Exposure by Drinking Water
Abstract
Epidemiological studies have linked arsenic to skin and bladder cancer and more recently 
to cardiovascular disease, although the mechanisms are primarily unknown. This is the 
first laboratory controlled study confirming a connection between arsenic intake and 
cardiovascular disease in mice. The results revealed a gross increase in the size of the 
atherosclerotic plaques occluding the innominate artery of ApoE"A/LDLr'A mice treated 
with 10 ppm (133.3 fiM) arsenic in drinking water for 18 weeks. Immunohistochemistry 
showed nitrotyrosine formation was significantly higher within the atherosclerotic plaque 
of arsenic-treated mice. We conclude that amplified synthesis of reactive species, such as 
peroxynitrite, results in increased protein nitration in response to arsenic exposure and 
contributes to the pathology of arsenic-induced cardiovascular disease.
Introduction
Epidemiological studies have linked arsenic to cardiovascular disease throughout the 
world. Regions of Taiwan, Bangladesh, Argentina and others have exceedingly high 
concentrations of arsenic in the groundwater. These areas suffer from a high incidence of 
cancer and severe peripheral and cardiovascular disease. In a long-term study in Taiwan, 
there was a significant association between cumulative arsenic consumption through 
artesian well water and prevalence of carotid atherosclerosis (Wang et al., 2002). The 
data were consistent regardless of the duration of exposure, the average arsenic
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concentration within the water, or cumulative arsenic exposure and remained significant 
after adjusting for known risk factors in the development of atherosclerosis (Wang et al., 
2002). In the United States, an investigation on the relationship between population- 
weighted mean arsenic concentration in public drinking water and death from 
cardiovascular diseases (CVD) in 30 U.S. counties showed an increase in the mortality 
ratio for various forms of CVD (Engel and Smith, 1994). These included diseases of the 
arteries, arterioles, and capillaries as well as an elevation in the incidence of 
arteriosclerosis and aortic aneurysm with a mean arsenic concentration greater than 2 0  
parts per billion (ppb).
Atherosclerosis is a disease characterized by chronic inflammation and arterial 
occlusion. Atherogenesis is a multifactorial process, making elucidation of a single 
mechanism for exacerbation of the disease difficult. In humans, primary risk factors 
include genetics, obesity, cigarette smoking, hypertension, diabetes mellitus, and 
increased serum cholesterol. However, the initiating event appears to be activation of the 
endothelial lining within the arteries leading to a cascade of changes in cell signaling and 
increases in oxidative stress and inflammation (Keaney, 2000).
Changes in the oxidative and inflammatory state of a system are not mutually 
exclusive. There is increasing evidence linking stress due to the formation of reactive 
oxygen and nitrogen to inflammation. In fact, peroxynitrite, an extremely reactive isomer 
of the nitrate anion has been linked to atherosclerosis through the detection of 
nitrotyrosine (3NY) residues within the plaque (Beckmann et al., 1994; Leeuwenburgh et 
al., 1997). In biological samples, 3NY has been used as a marker for the presence of 
peroxynitrite (Crow and Ischiropoulos, 1996). Recently, a link between the formation of
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peroxynitrite and induction of cyclooxygenase-2 (COX-2) in rheumatoid arthritis was 
reported (Migita et al., 2002), and we have shown an increase in both peroxynitrite 
synthesis and COX-2 in endothelial cells exposed to arsenic (Bunderson et al., 2002). 
Oxidants have been shown to cause changes in the activation state of transcription factors 
and other proteins by altering phosphorylation patterns or introducing conformation 
changes through disulfide bonds and intramolecular disulfide bridges (Herrlich and 
Bohmer, 2000). Changes in these important cellular processes can lead to activation of 
the endothelial lining of the vasculature and recruitment of inflammatory mediators 
resulting in initiation and eventually, exacerbation of atherosclerosis (Libby, 2002).
While there is clear evidence linking arsenic to increases in CVD, the 
mechanisms behind this phenomenon are primarily unknown. Considering the 
tremendous impact of CVD to this country and the recently reduced standard for arsenic 
in the drinking water by the EPA, studies determining these mechanisms are needed.
This is the first laboratory controlled study demonstrating a direct link between arsenic 
exposure in the drinking water and exacerbation of atherosclerosis.
Materials and Methods
Mice and dissection procedures. ApoE'/7LDLr'/' mice were obtained from 
Jackson Laboratories, maintained in specific pathogen free conditions according to 
IACUC protocols, and treated with 133 /nnol/L (10 ppm) sodium arsenite via the 
drinking water. Following 18 weeks of treatment, the mice were formaldehyde perfused 
(1 %/PBS), then the heart and innominate artery were removed, fixed, sectioned and 
processed for Movats staining similar to published protocols (Rosenfeld et al, 2000).
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Sections from each mouse were examined under a NikonE800 microscope, the area of the 
lumen (L) and plaque (P) were measured using NIH ImageJ, then the L/P ratios from the 
water only control and As treated group were statistically compared using an unpaired t- 
test.
Immunohistochemistry. Sections (described above) from As treated and control 
mice were deparaffinized, rinsed in tris buffer (TB, pH= 8.0) blocked for endogenous 
peroxidase with 3% H2O2 solution/TB then blocked with 5% BSA7 4% goat serum/TB 
for 30 min. Anti-3NY polyclonal serum (Upstate Biotechnology) in blocking solution 
was applied at 5 jtig/mL overnight at 4°C. The next day, the sections were rinsed (3X5 
min. TB), then goat anti-rabbit biotin conjugated secondary antibody (Vector 
Laboratories) was applied at 1:400 for 1 h. The samples were rinsed (3X5 min. TB), 
developed with Vectastain Elite ABC kit (Vector Laboratories), dehydrated and 
coverslipped. Sections were examined with a NikonE800 microscope, photographed and 
analyzed with ImageJ for calculation of the mean grey and total plaque area.
Results and Discussion
This study provides laboratory-controlled evidence to support the epidemiological 
studies linking arsenic to CVD. We used the highly atherogenic ApoE'/_ /LDLr_/" mouse 
model. These mice develop severe occlusions early in life while fed a normal chow diet. 
It is well known that the ApoE lipoprotein is important for the cardioprotective effects of 
high-density lipoproteins (HDL) and is also a ligand for the low-density lipoprotein 
(LDL) receptor and vital for removal of cholesterol from the blood (Strittmatter and Bova 
Hill, 2002). The innominate artery has been shown to have the greatest similarities with
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Figure 10. Staining and quantification of ApoE^TLDLr1' '  innominate artery
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Figure 10. (A) Innominate artery stained with movat’s from ApoE^'/LDLr'7' mouse given 
ddHaO for 18 weeks. (B) Innominate artery stained with movat’s from ApoE'VLDLr^* 
mouse given 10 ppm (133.3 pM) sodium arsenite in ddHhO for 18 weeks. (C) Changes 
in occlusion between control (n=9) and treated (n=7) mice measured as lumen 
area/internal elastic lamina area. P=.0025
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the human form of atherosclerosis in an ApoE'7' mouse model (Rosenfeld et al, 2000). 
We observed a significant increase in the atherosclerotic occlusion of the innominate 
artery of apoE'^/LDLr7' mice treated with 10 ppm (133.3 jiM) arsenic for 18 weeks 
(Figure lOa-c). Changes in intima media thickness of the coronary artery in humans is 
correlated with increases in blood pressure, smoking, and high LDL cholesterol—all risk 
factors in the development of heart disease (Sinha et al, 2002).
Arsenic is a ubiquitous contaminant within our environment (Abernathy et al., 
1999) and also merits consideration as a risk-factor for atherosclerosis. Arsenite is 
considered to be the most toxic form of inorganic arsenic (Buchet and Lison, 2000). The 
mechanisms by which arsenic contributes to atherosclerosis are not folly understood, 
however, our findings suggest that generation of reactive species plays a role. Arsenite in 
particular has been shown to activate an NAD(P)H oxidase found on the plasma 
membrane of vascular endothelial cells (Smith et al, 2001) and vascular smooth muscle 
cells (Lynn et al, 2000). Activation of these membrane-bound oxidases leads to 
increased production of reactive oxygen species, particularly superoxide anion ((V ). 
Superoxide anion combines with nitric oxide (NO ) to form an extremely reactive isomer 
of the nitrate anion, peroxynitrite. There is substantial evidence suggesting that 
peroxynitrite is responsible for the nitration of both free and protein-bound tyrosine 
residues (Beckman and Koppenol, 1996). This has implications for disruption of cell- 
signaling cascades as well as basic cellular functions such as inadequate folding of 
secondary and tertiary protein conformation patterns. In addition, peroxynitrite has been 
shown to oxidize LDL molecules, a known component of atherogenesis (Keaney, 2000).
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3NY residues in biological samples have been used as a marker for the presence 
of peroxynitrite (Crow and Ischiropoulos, 1996). In fact, atherosclerosis has been 
characterized by a general, and in some cases marked increase in the occurrence of 3NY 
residues (Beckmann et al, 1994; Leeuwenburgh et al, 1997). Our laboratory previously 
demonstrated an increase in the synthesis of peroxynitrite upon exposure to arsenic in 
vascular endothelial cells (Bunderson et al, 2002). We confirm this finding in the 
present study by demonstrating that the biomarker of peroxynitrite, 3NY, is found in 
greater abundance within the plaque of arsenic-treated mice than controls (Figure 11 a-d). 
This could provide a stimulus for endothelial cell dysfunction. Damage to the endothelial 
lining of the vasculature is believed to be a primary component in the pathophysiology of 
atherosclerosis (Callow, 2002). Vascular endothelial cells normally serve as a barrier to 
regulate the movement of fluid and various proteins from the blood to the interstitium 
(Yoshikawa, 2002). However, disruption of the normal cellular signaling pathways or 
mechanical injury to the artery results in a cascade of events leading to the early 
formation of plaque (Yoshikawa, 2002). In its simplest form, this increase in reactive 
species would result in modification of lipoproteins and subsequent uptake by the 
scavenger receptor on the macrophage leading to foam cell formation. Perhaps more 
importantly, an increase in the oxidative stress within the endothelial lining may result in 
an upregulation of inflammatory mediators such as vascular cell adhesion molecule- 1 and 
subsequent monocyte recruitment to the injured area (Libby, 2002).
Arsenic has been shown to increase the risk of CVD, first through 
epidemiological studies, and now through a laboratory-controlled mouse model. This 
exacerbation of a highly complex disease can partially be explained by arsenic’s ability
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Figure 11. 3NY Immunohistochemistry of ApoE^'/LDLr7' innominate artery
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Figure 11. (A) Innominate artery of ApoE'^/LDLr'7' mouse given ddH20  for 18 
weeks and stained for 3NY using immunohistochemical techniques. Top: 3,3’- 
Diaminobenzidine (DAB) staining Bottom: DAB stained sample converted to 
grayscale and a density threshold set (minimum=40 maximum=175). (B)
Innominate artery of ApoE"/7LDLr*/' mouse given ddH20  containing 10 ppm (133.3 
pM) sodium arsenic for 18 weeks and immunostained for 3NY. Top: DAB staining 
Bottom: DAB stained sample converted as described above (C) Innominate artery of 
a control mouse stained with antibody preincubated with a 3NY solution as a negative 
control. Top: DAB staining Bottom: DAB stained sample converted as described 
above (D) Changes in density of 3NY staining between control (n=9) and treated 
(n=7) mice measured as mean gray/plaque area. P=.046.
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to increase synthesis of reactive oxygen and nitrogen species resulting in oxidative 
stress and inflammation, hallmarks of atherosclerosis.
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CHAPTER THREE
Induction of 5-lipoxygenase and changes in the important inflammatory mediators, 
leukotrienes and prostanoids, are observed in arsenic-induced atherosclerosis.
Abstract
Numerous epidemiological studies have linked arsenic in drinking water to cancer 
and more recently to cardiovascular disease. Although an association between arsenic 
exposure and atherosclerosis has been established, the mechanisms are primarily 
unknown. Atherosclerosis is an inflammatory disease. Therefore, any agent that 
enhances vasculature inflammation may facilitate atherosclerosis. Previously, our 
laboratory established an induction of the cyclooxygenase-2 (COX-2) protein in bovine 
aortic endothelial (BAE) cells exposed to arsenic (Bunderson et al., 2002). Also, we 
have shown that arsenic exposure enhances atherosclerotic occlusions in the innominate 
artery of ApoE^'/LDLr7' mice (see Chapter 2). Therefore, the goal of this study was to 
determine the effect of arsenic exposure on a second inflammatory mediator, 5- 
lipoxygenase (5-Lo), thought to be involved in the atherosclerotic process. In addition, 
expression of both COX-2 and 5-Lo in the atherosclerotic plaques of the ApoE'^/LDLr'7' 
atherogenic mouse model was examined as well as leukotriene and prostaglandin 
synthesis after exposure to arsenic. Using Western immunoblots, we show that 5- 
lipoxygenase is upregulated in a time-dependent manner in response to arsenic exposure 
in bovine aortic endothelial (BAE) cells, but no changes in the expression of 5-Lo or 
COX-2 within the atherosclerotic plaque were observed between control and treated 
mice. There was an increase in LTE4 but not LTB4 synthesis in response to arsenic
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exposure both in vitro and in the serum of arsenic-treated mice. In addition, two products 
of COX-2 were measured in vivo after arsenic treatment, prostaglandin E2 (PGE2) and 
prostacyclin (PGI2). There were no changes in the proinflammatory PGE2 but a 
significant increase in PGI2. This study demonstrates arsenic’s ability to influence the 
dynamic nature of inflammatory pathways that have been associated with atherogenesis.
Introduction
Cardiovascular disease is the leading cause of morbidity and mortality in the 
Western World. Principle among cardiovascular diseases is atherosclerosis, which often 
results in the manifestation of heart attack and stroke. Epidemiological studies have 
linked arsenic to cardiovascular disease throughout the world, including regions of 
Taiwan, Bangladesh, Argentina, and others with exceedingly high concentrations of 
arsenic in the groundwater. In a long-term study in Taiwan there was a significant 
association between cumulative arsenic consumption through artesian well water and the 
prevalence of carotid atherosclerosis (Wang et ah, 2002). In the United States, an 
investigation on the relationship between population-weighted mean arsenic 
concentration in public drinking water and death from cardiovascular diseases (CVD) in 
30 U.S. counties showed an increase in the mortality ratio for various forms of CVD 
(Burleigh et al., 2002). These included diseases of the arteries, arterioles, and capillaries 
as well as an elevation in the incidence of arteriosclerosis and aortic aneurysm with a 
mean arsenic concentration greater than 20 parts per billion (ppb). The mechanisms 
behind arsenic-induced cardiovascular disease are primarily unknown, and our laboratory 
only recently provided the first direct laboratory-controlled evidence linking arsenic to
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CVD (See chapter two). Atherosclerosis is a disease characterized by chronic 
inflammation and arterial occlusion and is a multifactorial process, making elucidation of 
a single mechanism for exacerbation of the disease difficult. However, an initiating event 
appears to be activation of the endothelial lining leading to a cascade of changes in cell 
signaling and increases in oxidative stress and inflammation (Keaney, 2000).
Our laboratory previously showed that arsenic induces the inflammatory 
mediator, COX-2 in aortic endothelial cells (Bunderson et al., 2002) and at high 
concentrations of arsenic (20 pM), increases in the COX-2 product, prostaglandin E2 
(PGE2), were also observed. Recently, another inflammatory pathway closely related to 
the cyclooxygenase system has been recognized as an important component of 
atherogenesis. Mehrabian et al., (2002), identified a locus on mouse chromosome 6  that 
confers substantial resistance to atherogenesis as the 5-lipoxygenase (5-Lo) gene. A 
dramatic decrease (>26-fold) in the development of aortic lesions was observed in 5-Lo 
knockout mice. The enzyme 5-Lo metabolizes arachidonic acid to leukotriene A*
(LTA4) which is then converted to leukotriene B4 (LTB4) and the cysteinyl-leukotrienes 
(C4, D4, and E4), all of which are known to have proinflammatory effects. Furthermore, 
Allen et al., (1998), demonstrated an LTC4 and LTD4-dependent state of hyperactivity in 
atherosclerotic coronary arteries suggesting an increase in the 5-Lo enzyme.
In this study we demonstrate the importance of 5-Lo as an inflammatory mediator 
in the pathology of arsenic-exacerbated atherosclerosis.
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Materials and Methods
Mice. ApoE^TLDLr'7" mice were obtained from Jackson Laboratories, maintained 
in specific pathogen free conditions according to IACUC protocols, and treated with 133 
/rniol/L (10 ppm) sodium arsenite via the drinking water. Following 18 weeks of 
treatment, whole blood was obtained, allowed to coagulate and centrifuged for 1 0  min at 
10,000 rpm in a TOMY TX-160 centrifuge. The serum was collected and maintained at 
-80°C until used for ELISA analysis.
Dissection procedures. Following 18 weeks of treatment, dissection of the 
innominate arteries of the ApoE‘/7LDLr"/' mice was conducted according to published 
procedures (Rosenfeld et al., 2000). Briefly, mice were formaldehyde perfused 
(1 %/PBS), the heart and innominate artery removed, fixed, sectioned and stained using 
immunohistochemical techniques.
Immunohistochemistry. Cross-sections of the innominate arteries (described 
above) from arsenic treated and control mice were deparaffmized, rinsed in tris buffer 
(TB, pH= 8.0) blocked for endogenous peroxidase with 3% H2O2 solution/TB then 
blocked with 5% BSA/ 4% goat serum/TB for 30 min. Anti-COX-2 or 5-Lo polyclonal 
serum (Cayman Chemicals) in blocking solution was applied at 5 pg/mL overnight at 
4°C. The next day, the sections were rinsed (3 x 5 min. TB), and goat anti-rabbit biotin 
conjugated secondary antibody (Vector Laboratories) applied at 1:400 for 1 h. The 
samples were rinsed (3x5 min. TB), developed with Vectastain Elite ABC kit (Vector 
Laboratories), dehydrated and coverslipped. Sections were examined with a Nikon E800 
microscope, photographed and analyzed with the NIH program, frnageJ. DAB positive
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staining was converted to grey scale for calculation of the mean grey and total plaque 
area. Statistics were conducted using an impaired f-test P<0.05.
Cells. Bovine aortic endothelial cells (BAE), originally a gift from Dr. Steve 
Schwartz of the University of Washington, were provided by Dr. J. Douglas Coffin of 
The University of Montana Department of Pharmaceutical Sciences. Cell culture 
components were obtained from Life Technologies, Inc. (Rockville, MD) unless 
otherwise noted. BAE cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
with penicillin/streptomycin and L-glutamine, and supplemented with 15% fetal bovine 
serum (HyClone Laboratories, Inc., Logan, UT). The cells were incubated at 37°C under 
a humidified atmosphere containing 5% C02- BAE cells were used between passages #2- 
8 .
Western Blot. BAE cells were grown to approximately 90% confluency and 
treated with 10 pM sodium arsenite for 0.5,1,24 and 48h. Cells were harvested with 2X 
Laemmli buffer, homogenized with an 18 and 25 gauge needle and boiled for 5 min. 
Protein concentrations were determined by a Bradford assay (Biorad, Hercules, CA), and 
samples (10 pg) were loaded onto a 10% SDS gel. After protein separation, the samples 
were transferred to a polyvinylidenedifluoride (PVDF) membrane and probed for 5- 
lipoxygenase (5-Lo) protein using a rabbit polyclonal 5-Lo antibody (Cayman 
Chemicals) and an anti-rabbit secondary antibody conjugated with horseradish 
peroxidase (Vector Laboratories). 5-Lo was visualized by enhanced chemiluminescence 
(ECL; Amersham, Buckinghamshire, England).
ELISA. PGL was analyzed indirectly by measuring 6-keto prostaglandin Fi« using 
an immunoassay kit purchased from R&D Systems (Minneapolis, Minnesota) according
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to manufacturers instructions. Serum PGE2, LTE4, and LTB4 was analyzed using EIA 
immunoassay kits purchased from Cayman Chemicals (Ann Arbor, Michigan) according 
to manufacturers instructions. Arsenic treated BAE cells were analyzed for LTE4 
concentrations with or without the addition of the 5-lipoxygenase inhibitor AA861 (76.6 
pM), administered concomitantly with arsenic for 48h. Statistics were conducted using an 
unpaired f-test P<.05 for serum samples and ANOVA coupled with Dunn’s multiple 
comparison test for BAE samples P<.05.
Results
In addition to exacerbating atherogenesis by increasing oxidative stress (see 
Chapter 2), our laboratory has shown that arsenic induces the inflammatory mediator, 
COX-2 in aortic endothelial cells (Bunderson et al., 2002). At high concentrations of 
arsenic (20 pM), increases in the COX-2 product, prostaglandin E2 (PGE2), were also 
observed. However, we were unable to detect an increase in the presence of COX-2 in 
the arteries of our treated mice over the controls (Figure 12). We did observe an increase 
in prostacyclin (PGI2) (Figure 13), but not PGE2 (Figure 14) in the serum of the arsenic 
treated mice. Furthermore, we observed an increase in 5-Lo protein in bovine aortic 
endothelial cells treated with 10 pM arsenic over a period of 48 hours (Figure 15 a and 
b). In addition, we observed a significant increase in Leukotriene E4 (LTE4) synthesis in 
these cells after exposure to 10 pM arsenic for 48 h (Figure 15c). We were not able to 
detect an increase in 5-Lo within the innominate artery of our treated mice over controls 
(Figure 16), however, we were able to measure a significant increase in LTE4 (Figure 17), 
but not LTB4 (Figure 18) in the serum of these animals.
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Figure 12. COX-2 Immunohistochemistry of ApoE' TLDLr innominate artery
■ Control
■ 10 ppm As (III)
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Figure 12. (A) Innominate artery of ApoE^TLDLr7' mouse given ddHaO for 18 weeks 
and stained for COX-2 using DAB staining; sample converted to grayscale and a density 
threshold set (minimum=25 maximum=150j. (B) Innominate artery of ApoE'^/LDLr7' 
mouse given ddFhO containing 10 ppm (133.3 jxM) sodium arsenite for 18 weeks and 
stained for COX-2 using DAB staining; sample converted as described above (C) 
Changes in density of COX-2 staining between control and treated mice measured as 
mean grey/plaque area. Data not significant.
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Figure 13. Prostacyclin (PGl2)in the serum of ApoE'VLDLr mice.
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Figure 13. Prostacyclin (PGI2) in the serum of ApoE^VLDLr'7' mice given either ddFbO 
or ddFLO containing 10 ppm (133.3 /xM) sodium arsenite/ddELO for 18 weeks. PGI2 is 
estimated from the indirect measurement of the stable metabolite 6-keto prostaglandin Fi<* 
in the mouse serum using ELISA techniques. P<0.01
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Figure 14. BicycloProstaglandin E2 (PGE2)measured by ELISA technique in the
serum of ApoE^TLDLr^' mice.
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Figure 14., Bicycloprostaglandin E2  (PGE2) measured by ELISA technique in the serum
of ApoE'7'/ LDLr_/' mice given either ddELO or 10 ppm (133.3 fiM) sodium
arsenite/ddFLO for 18 weeks. Data not significant.
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Figure 15. BAE cells treated with 10 jiM sodium arsenite
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Figure 15., (A) Western blot analysis of 5-lipoxygenase in bovine aortic endothelial cells 
treated with 10 pM sodium arsenite at various time points, representative of two separate 
experiments. (B) Ratio between densitometry of 5-Lo and actin bands from blot in “A” 
(C) Leukotriene E4 measured by ELISA technique in bovine aortic endothelial cells with 
a range of sodium arsenite concentrations with or without AA-861, a 5-lipoxygenase 
inhibitor, for 48 h. P<.05
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Figure 16. 5-Lo Immunohistochemistry of ApoE'TLDLr" innominate artery
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Figure 16. (A) Innominate artery of ApoE^TLDLr7' mouse given ddEbO for 18 weeks 
and stained for 5-Lo using DAB staining; sample converted to grayscale and a density 
threshold set (minimum=25 maximum=150). (B) Innominate artery of ApoE^TLDLr'7’ 
mouse given ddELO containing 10 ppm (133.3 fiM) sodium arsenite for 18 weeks and 
stained for 5-Lo using DAB staining; sample converted as described above (C) Changes 
in density of 5-Lo staining between control and treated mice measured as mean 
grey/plaque area. Data not significant.
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Figure 17. Leukotriene E4 measured by ELISA technique in the serum of ApoE‘A
/LDLr'7' mice.
800.00
700.00
600.00 -
500.00
400.00 -
300.00 -
200.00
100.00  -
■ Control
■ 10 ppm As (III)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 17. Leukotriene E4  measured by ELISA technique in the serum of ApoE'V
LDLr'/_ mice given either ddH20 or 10 ppm (133.3 /xM) sodium arsenite/ddH2 0  for 18
weeks. P<0.05
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Figure 18. Leukotriene B4 measured by ELISA technique in the serum of ApoE"7'
/LDLr'/_ mice.
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Figure 18., Leukotriene B4  measured by ELISA technique in the serum of ApoE7'/
LDLr7' mice given either ddELO or 10 ppm (133.3 juM) sodium arsenite/ddHaO for 18
weeks. Data not significant.
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Discussion
We previously described the first laboratory-controlled evidence to support the 
epidemiological studies linking arsenic to CVD. In the ApoE^'/LDLr'7' mouse model, we 
observed a significant increase in the degree of occlusion in the innominate artery (see 
chapter two). In the current study we used two models in order to examine possible 
mechanisms for arsenic’s role in contributing to cardiovascular disease. First, we used 
the BAE cell line in order to establish pathways involving the endothelium that would 
contribute to atherosclerosis. Dysfunction of the endothelial lining of the vasculature is 
believed to be a primary component in the pathophysiology of atherosclerosis (Callow, 
2002). Vascular endothelial cells normally serve as a barrier to regulate the movement of 
fluid and various proteins from the blood to the interstitium (Yoshikawa, 2002).
However, disruption of the normal cellular signaling pathways or mechanical injury to 
the artery results in a cascade of events leading to the early formation of plaque 
(Yoshikawa, 2002). Our laboratory previously showed an increase in the reactive 
nitrogen species, peroxynitrite, in response to arsenic exposure (Bunderson et al., 2002). 
This could provide just such a stimulus for endothelial dysfunction. In its simplest form, 
this increase in reactive species would result in modification of lipoproteins and 
subsequent uptake by the scavenger receptor on the macrophage leading to foam cell 
formation. Perhaps more importantly, an increase in the oxidative stress within the 
endothelial lining may result in an upregulation of inflammatory mediators such as 
vascular cell adhesion molecule-1 (VCAM-1) and subsequent monocyte recruitment to 
the injured area (reviewed in Libby, 2002).
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In addition to the endothelial cells, we used the highly atherogenic ApoE'A/LDLr 
mouse model. These mice develop severe occlusions early in life while fed a normal
i
chow diet. It is well known that the ApoE lipoprotein is an important component of the 
cardioprotective effects of high-density lipoproteins (HDL) and is also a ligand for the 
low-density lipoprotein (LDL) receptor and vital for removal of cholesterol from the 
blood (Strittmatter and Bova Hill, 2002). Exposure to arsenic significantly increases the 
degree of occlusion within the innominate artery (See chapter two).
The mechanisms underlying arsenic’s ability to exacerbate atherosclerosis are 
mostly unknown. There are many potential steps in the development of atherosclerosis 
which may be impacted by exposure to arsenic. Current theories on the development of 
atherosclerosis underscore the pathology as a “process” that is first characterized by 
endothelial cell dysfunction, followed by the formation of foam cells due to uptake of 
oxidized lipoproteins by macrophages, proliferation of vascular smooth muscle cells, and 
exacerbation by the inflammatory process which may eventually lead to rupture of 
“vulnerable” plaque (Frohlich and Lear, 2002). Specifically, inflammatory conditions 
within the vasculature (such as ischemia/reperfusion) have been shown to be associated 
with adhesion of platelets to the vascular endothelium predisposing an individual to 
thrombosis and occlusion of the vasculature, although thrombotic events have not been 
characterized in mouse models of atherogenesis (Greaves and Channon, 2002).
In addition to the “workhorse” proteins, such as VCAM-1, changes in 
inflammatory modulators such as the prostaglandins and leukotrienes contribute to the 
pathology of atherosclerosis (Burleigh et al., 2002; Walker et al., 2002; Mehrabian et al., 
2002; Gurm et al, 2003). Prostaglandins and leukotrienes are products of the
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cyclooxygenase and lipoxygenase pathways, respectively. These may be important 
pathways by which arsenic is a factor in the pathogenesis of atherosclerosis. Specifically, 
our laboratory has previously shown COX-2 to be upregulated in response to arsenic 
exposure in the endothelial cell line and at 20 pM arsenic there was a significant increase 
in PGE2 (Bunderson et al., 2002). Burleigh et al., (2002) demonstrated the importance 
of COX-2 in the early stages of lesion formation using LDL receptor-deficient mice. We 
observed an increase in the COX-2 product, PGI2, in the serum of our arsenic treated 
mice although we did not see an increase in PGE2 within the serum of the treated mice. 
This is reflected in the immunohistochemistry data that showed no increase in the COX-2 
protein within the plaque of arsenic-treated versus control mice. It is possible that the 
increase in PGI2 is a response to changes in prostacyclin synthase, an enzyme 
dovynstream from the cyclooxygenase enzymes in the eicosanoid biosynthetic pathways. 
Salzman and Bowman (1992) saw a similar effect on PGI2 synthesis in fibroblast cells 
treated with sodium arsenite. It has been suggested that PGI2 may serve as a stabilizing 
response to increased platelet-vessel wall interactions (Cheng et al, 2002). It is also a 
potent vasodilator and may be a physiological attempt to counteract the rapid 
development of plaque within the arteries of the arsenic-treated mice.
Presently, we have demonstrated an increase in 5-Lo protein in the aortic 
endothelial cell line and observed a concurrent increase in LTE4 both in the arsenic- 
treated cells and the serum of the arsenic-treated mice. However, no significant changes 
in the presence of 5-lipoxygenase in the plaque of arsenic-treated versus control mice 
suggests activation of other enzymes is involved in the increased synthesis of LTE4 in 
response to arsenic exposure. It is possible that increases in the activation of
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phospholipaseA2 and the resulting increase in arachidonic acid cleavage from membrane 
phospholipids contributes to available substrate pools for 5-Lo. Therefore, the increase in 
LTE4 observed would be due to increased enzyme activity rather than overall protein 
induction. However, no significant change in the highly vasoconstrictive and 
chemotactic LTB4 suggests that an increase in LTC4 synthase (see figurel) is a more 
likely explanation. In addition, induction of 5-Lo within the vascular endothelium may 
be sufficient to explain the increases in LTE4 irrespective of changes in protein 
expression within the plaque itself.
An increase in leukotriene synthesis may contribute to atherosclerosis in various 
ways. The conversion of arachidonic acid to the various leukotrienes involves an 
oxygenation step and formation of unstable epoxides (Samuelsson et al., 1987). As a 
result, lipoxygenase activity may contribute to the progression of atherosclerosis simply 
by oxidizing LDL lipids (Cathcart and Folcik, 2000). The cysteinyl leukotrienes, 
including LTE4, have also been shown to increase vascular permeability, facilitate 
smooth muscle cell chemotaxis, and serve as potent vasoconstrictors—all of which would 
exacerbate atherosclerosis.
Arsenic has been shown to increase the risk of cardiovascular disease, first 
through epidemiological studies, and recently in a laboratory-controlled mouse model. 
This exacerbation of a highly complex disease can be explained at least partially by 
arsenic’s ability to increase synthesis of reactive oxygen and nitrogen species resulting in 
oxidative stress, a hallmark of atherosclerosis. Furthermore, increases in key markers of 
inflammation in response to arsenic exposure demonstrate a long reaching impact on all 
phases of development of cardiovascular disease.
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CHAPTER FOUR
Peroxynitrite Generation in Aortic Endothelial Cells Exposed to Arsenic is 
Increased by Manganese
Abstract
Long-term exposure to arsenic in drinking water has been linked to cancer and other 
health effects, including cardiovascular disease. Arsenic is found in combination with a 
range of metals that could influence the toxicity of arsenic. Manganese, in particular, is a 
metal that is typically found in conjunction with arsenic in contaminated groundwater. 
Two potential mechanisms for arsenic-induced cardiovascular disease include the 
formation of peroxynitrite, a highly reactive oxidant and nitrating agent with a high 
affinity for tyrosine residues; and an enhanced immune response. Nitrotyrosine, a 
biological marker for the presence of peroxynitrite, is found in high levels in the plaques 
of individuals with coronary heart disease—a disorder characterized by chronic 
inflammation. The goal of this study was to examine the effects of manganese on arsenic- 
induced toxicity and peroxynitrite formation in endothelial cells. The effect of manganese 
on arsenic toxicity was determined in bovine aortic endothelial (BAE) cells using the 
MTT assay. Arsenic toxicity was potentiated by the addition of manganese at manganese 
concentrations that were non-toxic when administered alone. BAE cells were also used to 
measure the generation of peroxynitrite in the presence of arsenic, manganese and 
arsenic-manganese mixtures. Supernatant from treated cells was also used to measure 
changes in the inflammatory mediator, PGE2. We have previously shown that arsenic 
increases peroxynitrite formation at low concentrations (0.25 pM) and PGE2 at high
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concentrations (20 pM) using this model. BAE cells were exposed to sodium arsenite, 
manganese chloride or an arsenic-manganese mixture for 1 h. Peroxynitrite was measured 
indirectly by its ability to oxidize hydroethidine to its fluorescent form, ethidium, in the 
presence of superoxide dismutase and catalase. PGE2 was measured using a standard 
Enzyme Immunoassay (EIA) kit. There was a significant increase in the amount of 
fluorescence emitted from arsenic, manganese, and arsenic-manganese mixture-treated 
cells compared to control cells. Individually, arsenic and manganese enhance 
peroxynitrite formation by 50% over the controls at 5 pM arsenic and 25 pM manganese. 
However, given together at equivalent concentrations, peroxynitrite formation was 
increased 2-fold versus controls. These data suggest that manganese may exacerbate the 
toxic effects of arsenic on the vascular system.
Introduction
Over 60 million Americans have one or more types of cardiovascular disease 
(CVD). CVD is the number one killer in the United States, costing over $300 billion per 
year. Arsenic exposure has been identified as a risk factor for CVD in a number of 
epidemiological studies (Engel and Smith, 1994; Chen et al., 1996; Hertz-Picciotto et al., 
2 0 0 0 ), and specific diseases that have been linked to chronic arsenic exposure include 
atherosclerosis (Wang et al., 2002), ischemic heart disease (Tseng et al., 2003), and 
hypertension (Rahman et al., 1999). A better understanding of the role for arsenic in 
CVD could lead to prevention or treatment strategies for CVD. Historically, arsenic has 
been released into the air, soil and water by human activities such as mining, smelting, 
manufacturing and pesticide application. An important source of arsenic exposure for
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humans is drinking water. Most public water supplies have low levels (less than 10 ppb) 
of arsenic, but many areas of the U.S., especially the western states, are known to have 
much higher levels (Buchet and Lison, 2000; Engel and Smith, 1994).
Arsenic has been shown to increase levels of reactive oxygen species such as 
superoxide anion and hydrogen peroxide in endothelial cells (Lynn et al, 2000). 
Peroxynitrite is a powerful oxidant that is the product of a rapid reaction between 
superoxide anion and nitric oxide. We have generated evidence for peroxynitrite 
formation in bovine aortic endothelial cells exposed to sodium arsenite (Bunderson et al., 
2002). Peroxynitrite has been implicated in the oxidation of low-density lipoprotein 
(LDL) to a form recognizable by macrophage scavenger receptors, one of the putative 
first steps in atherogenesis (Keaney, 2000). There is substantial evidence linking in vivo 
production of peroxynitrite with nitration of both free and protein bound tyrosine residues 
(Beckman, 1996). Atherosclerosis is characterized by a general, and in some cases 
marked, increase in the occurrence of nitrotyrosine residues (Beckmann et al, 1994; 
Leeuwenburgh et al, 1997).
The question of how metals impact arsenic toxicity has not been well studied. Of 
particular interest is the effect of manganese due to its high levels at hazardous waste 
sites related to large scale mining activities (Moore and Luoma, 1990). Although 
manganese alone does not seem to be problematic with regard to CVD (Houtman, 1996), 
little is known of its effect in combination with arsenic. In this study, we evaluated the 
effect of manganese on arsenic toxicity and peroxynitrite generation in endothelial cells, 
and the production of the proinflammatory prostaglandin, PGE2, in cell culture media 
from those cells.
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Materials and Methods
Cell Culture. Bovine aortic endothelial (BAE) cells from primary cultures were a 
gift from Dr. Steve Schwartz of the University of Washington. Cell culture components 
were obtained from Life Technologies, Inc. (Rockville, MD) unless otherwise noted. 
BAE cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) with 
penicillin/streptomycin and L-glutamine, and supplemented with 15% fetal bovine serum 
(HyClone Laboratories, Inc., Logan, UT). The cells were incubated at 37°C under a 
humidified atmosphere containing 5% C02- Cells were used between passages # 2-6.
Cell Viability Assay. Cell viability was determined using an adaptation of the 
MTT colorimetric assay (Mosmann, 1983). Cells were plated in 96-well plates at a 
density of 1-2 x 104 cells/mL and allowed to attach overnight (16 h). Sodium arsenite 
and selected metals were applied for the indicated times. Solutions were removed and 
replaced with medium alone, and the 96-well plates were incubated for 5-7 days. MTT 
(50 pg) was added to each well, and the cells were incubated for another 4 h. 
Medium/MTT solutions were removed carefully by aspiration, the MTT formazan 
crystals were dissolved in 100 pL DMSO and absorbance was determined on a plate 
reader at 550 nm. Cell viability was plotted as percent of control vs. concentration. 
Statistics were calculated using a one-way r-test with unequal variance.
Fluorimetric Determination o f Peroxynitrite. Peroxynitrite formation was 
determined using our published assay (Bunderson et al., 2002). Briefly, BAE cells were 
plated at a density of 10,000 cells/well on 96-well plates and allowed to attach overnight. 
Sodium arsenite, manganese chloride or a mixture of the two was added to the wells at
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the indicated concentrations and allowed to incubate for 1 h. The plates were rinsed twice 
with 100 pL of phosphate-buffered saline (PBS). Immediately following the rinses, 100 
pL of 40 pM hydroethidine/PBS solution was added with 25 U/mL of catalase and 
superoxide dismutase. The plates were read on a fluorescence plate reader at 465 nm 
excitation and 585 nm emission after a 15 min incubation period during which the plates 
were shaken every five min with the automatic plate shaker. Peroxynitrite formation was 
reported as percent of control (untreated cells). Statistics were conducted using a two- 
way unpaired t-test. *P<.05; **P<.005.
ELISA. PGE2 was analyzed using EIA immunoassay kits purchased from Cayman 
Chemicals (Ann Arbor, Michigan) according to manufacturers instructions.
Results
The toxicity of sodium arsenite to BAE cells was examined in mixtures 
containing metals (iron, copper, zinc, manganese) commonly found at waste sites related 
to mining activities (figure 19). Only manganese significantly increased the toxicity of 
arsenic at metal concentrations that were non-toxic when applied alone (Figure 20). 
Manganese is an essential element in mammalian systems, required for proper 
development and function (reviewed in Reaney et al., 2002), serving a role as an essential 
cofactor in glutamine synthetase, as well as various transferases, hydrolases and 
antioxidant pathways. Therefore, peroxynitrite and PGE2 formation in BAE cells was 
studied with sodium arsenite, manganese chloride and arsenic/manganese mixtures. One 
potential mechanism for manganese toxicity includes the formation of reactive oxygen 
species. Since arsenic is known to activate a membrane-bound NAD(P)H oxidase on
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vascular endothelial cells (Smith et al., 2001), manganese could exacerbate this increase 
in the oxidative state of the cell, either in a synergistic or additive fashion. Both arsenic 
and manganese increased peroxynitrite levels compared to controls (figure 2 1 ). 
Peroxynitrite formation for the arsenic/manganese mixtures was increased by a factor of 
two compared to arsenic and manganese alone. However, there were no significant 
changes in PGE2 synthesis after exposure to arsenic, manganese, or arsenic/manganese 
mixtures at these concentrations (figure 22). It could be that the presence of arsenic and 
manganese in conjunction with each other compromise the electron transport chain as 
both are known for disrupting the normal mitochondrial functions (Reaney et al., 2002; 
Nemeti and Gregus, 2002). This may partially explain the increase in toxicity observed 
with the mixture.
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Figure 19. Cell Viability of BAE Cells Exposed to Sodium Arsenite/Metal Mixtures.
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Figure 19. Cell Viability of BAE Cells Exposed to Sodium Arsenite/Metal Mixtures. The 
metals iron, manganese, copper and zinc were applied to BAE cells for 1 h along with 
sodium arsenite (1-100 pM). Concentrations ofFe[H] (10 pM), Mn[HJ (50 pM), Cu[H] 
(500 pM), and Zn[II] (500 pM) were used that were non-toxic when applied alone (data 
not shown). Error bars represent mean +/- standard deviation for n=3 experiments.
*P= 01 **P=. 006
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Figure 20. Cell Viability of BAE Cells Exposed to Sodium Arsenite/Manganese
Chloride Mixtures for 24 h (A) and 48 h (B).
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Figure 20. Cell Viability of BAE Cells Exposed to Sodium Arsenite/Manganese Chloride 
Mixtures. Sodium arsenite (1 pM, 5 pM, 10 pM) and manganese chloride (5 pM, 25 pM, 
50 pM) were applied separately, or in the same concentrations as a mixture, to BAE cells 
for 24 h (A) or 48 h (B). Error bars represent mean +/- standard deviation for n=3 
experiments. *P=.03 **P=.005
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Figure 21. Peroxynitrite Formation in BAE Cells Exposed to Sodium
Arsenite/Manganese Chloride Mixtures.
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Figure 21. Peroxynitrite Formation in BAE Cells Exposed to Sodium 
Arsenite/Manganese Chloride Mixtures. Sodium arsenite (1 pM, 5 pM, 10 pM) and 
manganese chloride (5 pM, 25 pM, 50 pM) were applied separately, or in the same 
concentrations as a mixture, to BAE cells for 1 h. Error bars represent mean +/- standard 
deviation for n=3 experiments. *P=.037 **P=.Oil ***P=.002
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Figure 22. Prostaglandin 1 2 Formation (% Control) in BAE Cells Exposed to
Sodium Arsenite/Manganese Chloride Mixtures.
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Figure 22. Prostaglandin E2 formation (% control) in BAE cells exposed to sodium 
arsenite/manganese chloride mixtures. Sodium arsenite (1 pM, 10 pM) and manganese 
chloride (5 pM, 50 pM) were applied separately, or in the same concentrations as a 
mixture, to BAJE cells for 1 h. Error bars represent mean +/- standard deviation for n=2 
experiments (6 -wells). Data not significant.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
135
Discussion
Elucidation of the mechanisms by which environmental contaminants exert their 
toxic effects is complicated by the fact that hazardous compounds are not found in the 
environment alone, but rather in conjunction with other compounds. The characteristics 
of the environment in which a toxicant such as arsenic is found may influence its 
solubility in water, bioavailability to plants and animals, rate of metabolism, and 
metabolic pathways. One potential mechanism for the wide diversity of cellular 
disturbances caused by arsenic is its ability to influence or be influenced by—other metals 
or toxicants. For example, the trivalent methylated form of arsenic, dimethylarsenic 
(DMA) has been shown to significantly increase the release of iron from horse spleen 
ferritin (Ahmad et al, 2000). Another example is the ability of arsenic to enhance the 
induction of both phase I and phase II detoxification enzymes caused by 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD) exposure, a common environmental pollutant 
resulting from application of pesticides contaminated with TCDD residues (Maier et al., 
2000). These could be pathways by which arsenic contributes to increased oxidative 
stress within an organism. Another metalloid, selenium, has been shown to influence the 
metabolism of arsenic (Csanaky and Zoltan, 2003). Selenium is an essential mineral yet 
highly toxic if ingested in large quantities. The interaction between selenium and arsenic 
in biological systems has been well established and at times both metalloids counteract 
the toxic effects of the other (Gregus et al., 2000). Finally, oral administration of 
inorganic arsenic to rats and guinea pigs has been linked to an accumulation of copper in 
the kidneys, although the biological consequence of this interaction is unknown 
(Ademuyiwa and Elsenhans, 2000).
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It is possible that metals/metalloids influence each other indirectly through the 
generation of reactive intermediates. This is relevant because atherosclerosis is a chronic 
inflammatory disease exacerbated by oxidative stress. Under conditions of stress, 
oxidation ofLDL and subsequent phagocytosis by macrophages leads to the formation of 
foam cells. These “fatty” macrophage cells die, leaving behind a growing mass of 
extracellular debris (Lusis, 2000). This will eventually cause arterial occlusion and 
disease. An increase in oxidative stress in response to arsenic exposure may contribute to 
atherosclerosis in various ways and be enhanced by the presence of other contaminants 
either in an additive or synergistic fashion.
The formation of reactive nitrogen species seems to play a particularly important 
role in atherogenesis, specifically arsenic-induced atherosclerosis, either by direct 
oxidation ofLDL (Ademuyiwa and Elsenhans, 2000), induction of inflammatory 
mediators (Gerszten et al, 2000), alterations of protein conformation via tyrosine 
nitration (Gow et al, 1996), or possibly through signaling pathways responsive to 
molecules such as peroxynitrite (Levonen et al., 2001). In the case of exposure to arsenic 
and arsenic/manganese mixtures, an increase in the formation of peroxynitrite could be a 
contributing factor in the aggravation of arsenic-related cardiovascular disease. In fact, 
peroxynitrite has been shown to influence the release of zinc from the zinc-thiolate 
cluster of endothelial NOS, possibly forming disulfide bonds between the enzyme 
monomers and decreasing NO synthesis (Zou et al, 2002). This has been related to 
increased generation of superoxide anion in diabetic mice and may also be important in 
the pathogenesis of atherosclerosis (Zou et al, 2002). Therefore, an increase in
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peroxynitqte in response to arsenic and arsenic/manganese mixtures may indirectly 
impact atherosclerosis by disrupting the normal cellular functions of zinc.
This study demonstrates that the presence of manganese enhances the formation 
of peroxynitrite in response to arsenic exposure—although mechanisms are unknown.
The combination of these two metals/metalloids is a common occurrence in the 
environment and may have serious consequences on the incidence of cardiovascular 
disease.
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CONCLUSIONS
Over 60 million Americans have one or more types of cardiovascular disease 
(CVD). CVD is the number one killer in the United States, costing over $300 billion per 
year. Arsenic exposure has been identified as a risk factor for CVD in a number of 
epidemiological studies (Engel and Smith, 1994; Chen et al., 1996; Hertz-Picciotto et al., 
2 0 0 0 ), and specific diseases that have been linked to chronic arsenic exposure include 
atherosclerosis (Wang et al., 2002), ischemic heart disease (Tseng et al., 2003), and 
hypertension (Rahman et al., 1999).
Exposure to arsenic and the resulting health effects are an important concern in 
Montana, where mining has resulted in the contamination of lakes, streams and aquifers 
(Moore and Luoma, 1990). As a consequence, Montana is home to a dense region of 
EPA designated superfund sites. The Milltown Reservoir Superfund Site (MRSS) is one 
such location. Located near Milltown, MRSS is an artifact of the Milltown Dam, built at 
the confluence of the Clark Fork and Blackfoot Rivers in 1907. Acting as a repository 
for sediment and mining wastes, the reservoir is highly contaminated and caused the 
formation of a groundwater arsenic plume that impacts Milltown's drinking water supply 
(USEPA). EPA added the site to its National Priorities List (NPL) in September 1983 
and is addressing the problem through the combined actions of federal and state agencies 
and the Potentially Responsible Parties (PRPs), primarily the Atlantic Richfield Company 
(ARCO) and the Northwestern Energy Corporation.
Arsenic contaminated drinking water has a huge impact on the health, 
environment, and economy of this country. Given the high incidence of cardiovascular
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disease and the associated costs, research aimed at understanding how arsenic may be 
contributing to the incidence of CVD is needed. The research done in our laboratory has 
aimed at elucidating some of those basic mechanisms by: (1) Defining the changes in 
key atherogenic regulatory proteins upon exposure to arsenic in bovine aortic endothelial 
cells (2) Investigating the effects of arsenic on the formation of peroxynitrite in 
endothelial cells (3) Determining the effects of arsenic on atherogenesis and expression 
of key CVD regulatory molecules in the ApoE'^/LDLr7' atherosclerotic mouse model and 
(4) Do preliminary experiments to determine the effects of other environmentally 
relevant metals on arsenic-induced cardiovascular disease.
COX-2, the inducible form of the COX protein, is a key player in inflammation 
and synthesis of prostaglandins by COX 1 and 2 is a necessary event in normal vascular 
physiology. Since atherosclerosis is an inflammatory disease, we reasoned that COX-2 
might play an important role in arsenic-induced atherogenesis. Expression of COX-2 
protein was measured by Western blot analysis using a polyclonal COX-2 antibody and 
chemiluminescence. The data show that COX-2 protein was increased after 30 min 
exposure to 5,10, and 20 pM arsenic. Furthermore, COX-2 induction was time 
dependent, showing a decline up to 24 h and then increasing again at 48 h. Densitometry 
using COX-2/actin ratios showed a twofold increase in COX-2 protein at 20 min and an 
over threefold increase after 48 h. No increase in COX-2 protein was observed at sodium 
arsenite concentrations less than 5 pM.
Peroxynitrite, the coupling product of nitric oxide and superoxide anion, is an 
oxidant that has been implicated in atherogenesis. Oxidant production was determined 
fluorimetrically by measuring the oxidation ofhydroethidine to its fluorescent form,
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ethidium. Hydroethidine is preferentially oxidized by superoxide anion, hydrogen 
peroxide, and peroxynitrite (Supinski et al., 1999; Al-Mehdi et al., 1997). Total reactive 
species increased in a dose-dependent manner up to 10 pM sodium arsenite. Addition of 
SOD and CAT had little effect on levels of reactive species, suggesting that peroxynitrite 
was the principal oxidant generated in endothelial cells by sodium arsenite. The general 
NOS inhibitor L-NAME or the NAD(P)H oxidase inhibitor DPI reduced fluorescence to 
control levels, confirming that peroxynitrite is primarily responsible for the fluorescence 
observed in arsenic-treated cells. Cell viability studies showed no toxicity to BAE cells 
treated with hydroethidine, DPI, or L-NAME at the concentrations and times used in 
these experiments.
Immunoprecipitation was used to confirm the formation of peroxynitrite and to 
determine the extent of COX-2 nitration upon arsenic exposure. COX-2 was 
immunoprecipitated from endothelial cells that were treated for 30 min with 5,10 and 20 
pM sodium arsenite. Western blots were then probed with an antinitrotyrosine antibody. 
Nitrated COX-2 was observed in cells treated with all concentrations of sodium arsenite, 
whereas there was no evidence for nitration of COX-2 in the non-arsenic-treated cells.
In addition to the in vitro model using BAE cells, we used the highly atherogenic 
ApoE'^/LDLr7' mouse model. These mice develop severe occlusions early in life while 
fed a normal chow diet. It is well known that the ApoE lipoprotein is important for the 
cardioprotective effects of high-density lipoproteins (HDL) and is also a ligand for the 
low-density lipoprotein (LDL) receptor and vital for removal of cholesterol from the 
blood (Strittmatter and Bova Hill, 2002). The innominate artery has been shown to have 
the greatest similarities with the human form of atherosclerosis in an ApoE‘/_ mouse
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model (Rosenfeld et al., 2000). We observed a significant increase in the atherosclerotic 
occlusion of the innominate artery of ApoEv7LDLrv' mice treated with 10 ppm (133.3 
pM) arsenic for 18 weeks. Changes in intima media thickness of the coronary artery in 
humans is correlated with increases in blood pressure, smoking, and high LDL 
cholesterol—all risk factors in the development of heart disease (Sinha et al., 2002).
As mentioned earlier, in addition to exacerbating atherogenesis by increasing 
oxidative stress, our laboratory has shown arsenic to induce the inflammatory mediator, 
COX-2 in aortic endothelial cells (Bunderson et al., 2002). At high concentrations of 
arsenic (20 pM), increases in the COX-2 product, prostaglandin E2 (PGE2), were also 
observed. However, we were unable to detect an increase in the presence of COX-2 in 
the arteries of our treated mice over the controls. We did observe an increase in 
prostacyclin (PGl2),but not PGE2 in the serum of the arsenic treated mice. Furthermore, 
we observed an increase in 5-Lo protein in bovine aortic endothelial cells treated with 10 
pM arsenic over a period of 48 h. In addition, we observed a significant increase in 
Leukotriene E4 (LTE4) synthesis in these cells after exposure to 10 pM arsenic for 48 h. 
We were not able to detect an increase in 5-Lo within the innominate artery of our treated 
mice over controls, however, we were able to measure a significant increase in LTE4, but 
not LTB4 in the serum of these animals. The relationship between increased synthesis of 
oxidants and inflammatory mediators is outlined in figure 23.
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Figure 23. Schematic overview of the mechanisms of action of arsenic-indnced 
cardiovascular disease
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The toxicity of sodium arsenite to BAE cells was examined in mixtures containing metals 
(iron, copper, zinc, manganese) commonly found at waste sites related to mining 
activities. Only manganese significantly increased the toxicity of arsenic at metal 
concentrations that were non-toxic when applied alone. Therefore, peroxynitrite and 
PGE2 formation in BAE cells was studied with sodium arsenite, manganese chloride and 
arsenic/manganese mixtures. Both arsenic and manganese increased peroxynitrite levels 
compared to controls. Peroxynitrite formation for the arsenic/manganese mixtures was 
approximately additive compared to arsenic and manganese alone. However, there were 
no significant changes in PGE2 synthesis after exposure to arsenic, manganese, or 
arsenic/manganese mixtures at these concentrations.
In conclusion, arsenic appears to play a primary role in endothelial cell 
dysfunction by activation of membrane oxidases that lead to formation of reactive species 
such as peroxynitrite. This also results in an overall increase in the oxidative stress 
experienced by the cell and probably contributes to such risk factors as modified 
lipoproteins and activation of intracellular monocytes and subsequent foam cell 
formation. Furthermore, an activation of inflammatory pathways such as COX-2 and 5- 
Lo would have a significant impact on the development of atherosclerosis. Particularly 
because these inflammatory mediators also influence vascular tone and may contribute to 
conditions of hypertension.
Extensive studies still need to be conducted in order to understand the impact that 
arsenic has on the immune system as a whole as well as cardiovascular performance. 
Furthermore, in depth characterization of the changes that occur within the plaque 
composition in response to arsenic may shed some insight into further pathways that are
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being disrupted in response to arsenic—leading to an increased understanding of the 
mechanisms of action of arsenic-induced cardiovascular disease.
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